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Catheter is a medical device inserted into body for administration of 
intravenous fluid, medication or drainage of body fluid etc. Central venous catheters 
(CVC), peripheral venous catheters (PVC), and urinary catheters are the commonly 
used catheters. The uses of catheters often lead to catheter associated infection (CAI). 
The most frequently identified causative agents of CAI include coagulase negative 
Staphylococci such as Staphylococcus epidermidis. Staphylococcus aureus, 
Escherichia coli, Enterobacter species, and Candida albicans. Candida albicans is an 
opportunistic pathogen infecting immunocompromised patients. The immune system 
of these patients is impaired and therefore they have a higher risk of acquiring CAI. 
Catheter associated infections related to Candida albicans can result in disseminated 
candidiasis. Understanding of the pathogenesis of CAI of Candida albicans helps to 
develop strategy for the prevention and treatment of CAI. Adhesion is the initial step 
to establish an infection. It was demonstrated that the more adhesive the Candida 
albicans is, the more pathogenic it is. Agglutinin-like sequence {ALS) gene family of 
Candida albicans includes 8 members {ALSl, ALS2, ALS3/ALS8, ALS4, ALS5, ALS6, 
ALS7, and ALS9). Gene products of ALSl, ALS3 and ALS5 were shown to contribute 
to the adhesion of Candida albicans to endothelial cells and FaDU epithelial cells. 
Understanding the molecular factors contributing to adhesion of Candida albicans 
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may help to improve our knowledge in CAI. The aim of this study is (i) to study the 
effect of inoculum size in an adhesion model of catheters and to establish a 
quantitation system for the adhesion model; and (ii) to study the effect of 
transformation of ALSl, ALS5 smaller allele, and ALS6 to Saccharomyces cerevisiae 
on its adhesion to human fibroblasts, and to tetrafluoroethylene and 
hexafloropropylene polymer (FEP), polyethylene, and silicone catheters. 
The study of effect of inoculum size revealed that adhesion of Candida 
albicans cells to the three catheters were not affected by the inoculum size of 1x10^, 
1x1 (>6，and 1x10)7 cells. An ATP bioluminescence assay was established as the 
quantitation system of the adhesion model of catheters. The linear range was 1x10^ to 
IxlO^cells. The detection limit was IxlO^ cells. Transformation of ALSl, ALS5 
smaller allele, and ALS6 conferred Saccharomyces cerevisiae adherence to human 
fibroblasts. Transformation of ALSl, and ALS6 conferred Saccharomyces cerevisiae 
adherence to FEP catheter fragments but not to polyurethane, and silicone catheter 
fragments. Transformation of ALS5 smaller allele did not confer Saccharomyces 
cerevisiae adherence to the three catheter fragments. 
It was concluded that adherence of Candida albicans to FEP, polyurethane, 
and silicone catheter was not affected by initial inoculum size of Candida albicans 
cells in the range from 1x10^ cells to 1x10^ cells. The ATP bioluminescence used in 
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this study was sensitive enough for adhesion assay aim at studying initial adhesion 
events when initial inoculum size was 1x10^ cells. ALSl, ALS5 smaller allele, and 
ALS6 contributed to adherence to human fibroblasts. These ALS genes contributed to 
differential adherence to FEP catheters but not to other catheters. 
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Chapter 1 Introduction 
1.1 Epidemiology of catheter associated infections 
1.1.1 Catheter associated infections (CAI) 
Catheters are widely used in health care settings. Intravascular catheters 
are used in the administration of blood products, total parenteral nutrition (TPN), fluid 
and electrolytes, and drugs (1). They are also used for hemodialysis (2)，monitoring of 
hemodynamics status in intensive care unit (ICU) (3). They are also used for the 
drainage of cerebrospinal fluids to control the cerebrospinal fluid pressure in brain or 
spinal cord, and drainage of urine. However, use of catheters is often followed by 
secondary infections or nosocomial infections. These infections were named as CAI 
(4). 
Clinical presentations of CAI vary, depending on the types of catheters 
used, the insertion site, and the duration of catheterization. Catheter associated 
infections can be categorized into local infections and systemic infections (5). Local 
CAI can be subclinical (5). Clinical presentations of local vascular CAI include 
inflammation, local pain, erythema, phlebitis, purulence and, in more serious cases, 
abscess, cellulitis, and septic thrombophlebitis (6). In systemic infections fever, 
bacteremia, leukocytosis, endocarditis, and dissemination of infection to bones, joints 
and other organs can be seen (5，6). Fever may be absent in the elderly or 
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immunocompromised patients (6). Again, systemic infections can be subclinical (5). 
There is no standard definition of CAI (7). Definitions served for 
surveillance purpose are different from those for clinical studies. The surveillance 
definitions for catheter associated bloodstream infections include all primary 
bloodstream infections in patients with an intravascular catheter when other sites of 
infection have been excluded. Primary bloodstream infection is defined as bacteremia 
or fungemia without documented distal source of infection (8). The clinical 
definitions for CAI include primary bloodstream infection with an intravascular 
catheter, presentation of fever, chills, and hypotension, no apparent site of infection in 
other source, and isolation of the same microorganism(s) from catheters as from the 
bloodstream (7，9). As clinical definitions are more stringent, more bloodstream 
infections will be considered as catheter associated when the clinical definitions are 
used. 
1.1.2 Risk and mortality of CAI 
Catheterization was considered to be the most significant single risk factor 
of nosocomial infections in several studies (1，7，10, 11). According to National 
Nosocomial Infections Surveillance System (NNIS) of the United States of America, 
eighty seven percent of primary bloodstream infections were associated with the use 
of central line (10). In the European Prevalence of Infection in Intensive Care (EPIC) 
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Study, the odd ratio of catheterization for bloodstream infections was 4.6, and the 
confidence interval was 3.1-6.8 (1). In another study, catheterization was found to be 
associated with 97% of urinary tract infections in ICU and the duration of 
catheterization was the most important risk factor for bacteriuria, ranging from 
2.3-22.4 days (11). The attributable mortality of central venous catheters associated 
bloodstream infections (CVCBSI) ranged from 14%-28% in different studies (12, 13， 
14). Central venous catheter associated bloodstream infections also resulted in a 6.5 
days of excess ICU stay in the United States (1). Urinary catheter associated 
infections (UCAI) also led to a 1 day increase in hospitalization. The mortality rate of 
UCAI ranged from 14%-19% (11). 
1.1.3 Etiology of CAI 
The microorganisms causing CAI can be recovered by direct culture of 
catheters removed from patients (Maki's role method), and by molecular detection 
(15). Microorganisms can also be observed on the surface of catheters by microscopy 
(3). In one study, microorganisms were observed on the external catheter surfaces 
from all 41 catheters associated with bacteremia (3). It was found that the number of 
microorganisms present on the external catheter surfaces correlated with the 
percentage of catheters with purulence at the insertion site in a rabbit model 
experiment (18). These findings support the idea that the clinical presentations of CAI 
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are microbiological in nature, instead of irritation due to catheters or infusates as in 
the case of aseptic phlebitis (3) and trauma due to insertion of catheter (16). 
The etiological microorganisms of CAI are numerous, depending on the 
catheter types, the insertion site, the purposes of the catheters, the nature of infusates, 
and the characteristics of patients. 
1.1.3.1 Venous catheters 
Several studies revealed that the first three etiological microorganisms in 
central venous catheter associated infections (CVCAI) are Staphylococcus 
epidermidis or coagulase negative Staphylococcus species (CoNS), Staphylococcus 
aureus, and Candida species (1，17, 18, 19, 20). Coagulase negative Staphylococci 
were the leading cause of peripheral venous catheter associated infections (PVCAI) in 
several studies, responsible for 96.7% of the PVCAI of adults in one study (3). It was 
followed by Staphylococcus aureus and yeast. Each accounted for 1.6% of PVCAI. 
These three microorganisms accounted for 99.9% of PVCAI. In the bloodstream 
infections associated with pulmonary artery catheters, the first three causes were also 
CoNS (37%), Staphylococcus aureus (26%) and Candida species (16%). Enteric gram 
negative bacilli species were also a significant cause (11%) (20). 
1.1.3.2 Urinary catheters 
The etiological microorganisms in UCAI are significantly different from 
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those in CVCAI. Escherichia coli accounted for 26% of UCAI, Enterococci, 16%, 
Pseudomonas aeruginosa, 12%, Candida species, 9%, and Klebsiella pneumoniae, 
6.4% (11). The etiological microorganisms of UCAI are different from CVCAI and 
PVCAI because the catheter insertion sites are different (2,11). 
The etiological microorganisms were also influenced by the characteristics 
of patients. For example, the most frequently identified microorganisms in the 
CVCAI of bums patients was Pseudomonas aeruginosa, instead of Staphylococcus 
epidermidis. Finally, the incidence of CAI due to gram positive microorganisms and 
fungi increased significantly in the last two decades (1). This may be due to the 
increase in liver transplant recipients (21) and immunocompromised, neutropenic 
patients (22). 
1.2 Pathogenesis of CAI 
Catheter associated infections begin with the colonization of 
microorganism(s) on the originally sterile catheters. The microorganisms colonized on 
catheter surfaces, then grow and excrete extracellular matrix, resulting in the 
formation of a biofilm (23). Subsequently, microorganisms may be released into 
surrounding fluids such as bloodstream and urine, depending on the surrounding 
anatomical structures of the catheters. The clinical presentations and the final outcome 
of CAI are the results of the interactions between hosts (the immunity of the patients, 
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the underlying diseases etc), pathogens (the virulence of pathogens, the ability to form 
biofilm (23)) and the environment (the duration of catheterization, the technique of 
insertion, the insertion sites, the materials of the catheters inserted) (6). 
1.2.1 Central venous catheters (CVC) 
The main sources of microorganisms in CVCAI are normal flora from the 
surrounding skin, contaminated catheter hubs, contaminated infusates or disinfectants, 
hematogenous seedings, and contiguous infections (3，17, 18, 24, 25). The source of 
colonizing microorganisms is related to the duration of catheterization. It was found 
that CVCs were first colonized by microorganisms from skin (average 5.1 days after 
insertion), then microorganisms from hematogenous seedings (average 8.6 days) and 
finally microorganisms from contaminated catheter hubs (average 13.1 days). The 
finding implicates different sources of microorganism for short term and long term 
CVCs. The microorganisms on the external surface of CVCs migrated to catheter tips 
by capillary action at the catheter-skin interface (25). Host proteins including 
albumins, fibronectins deposit on to the catheter tips surface almost immediately after 
insertion. Fibronectin, fibrin and fibrinogen can promote the adhesion of 
Staphylococcus aureus. Colonizing microorganisms accumulate and excrete 
extracelluar matrix such as slime or glycocalyx (3, 18，24). These slime and 
glycocalyx together with host tissue proteins, and platelets form biofilm and fibrin 
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sleeve surrounding catheters. A biofilm is a highly organized structure. It embeds the 
microorganisms on the catheter surface and protects the microorganisms from attack 
by circulating polymorphonuclear neutrophils, antibiotics and other stress. 
1.2.2 Urinary catheters 
Microorganisms enter the urinary bladder in UCAI through either 
extraluminal route or intraluminal route of urinary catheters. Microorganisms 
traveling through the extraluminal route are mainly endogenous microorganisms from 
the rectum. These microorganisms migrate through the mucus film surrounding the 
external surface of catheters. Microorganisms traveling through the intraluminal route 
are usually exogenous, due to reflux of urine in contaminated urine bags (11). 
1.3 Adhesion mechanisms 
1.3.1 Definition of adhesion 
Adhesion of microbial cells can be viewed as a population of originally 
free moving, randomly distributed microbial cells in air or in liquid concentrate on the 
interface between air or liquid and a surface (26). It is accompanied by a decrease in 
Brownian motion of microbial cells (27). In 1943，ZoBell proposed that adhesion of 
microbial cells could be described as a two-phase process. The first phase is a 
reversible step. Microbial cells are spontaneously attracted to a surface. Microbial 
cells on the surface are easily removed in this step. The second phase is a time 
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dependent irreversible step. Microbial cells adhere on a surface firmly and no 
Brownian motion is exhibited (27). This hypothesis was later confirmed by Marshall 
and associates. (27). Base on this observation, adhesion is defined by the time needed 
for achieving the irreversible step. The time needed has not been standardized. Some 
investigators defined adhesion as a process of microbial cells accumulating on a 
surface five minutes to two hours after addition of microbial cells (28). 
1.3.2 Adhesion mechanism 
Adhesion does not come naturally as the consequence of gravity. Rather, 
adhesion is the result of the interaction of different forces (29). Indeed, most surfaces 
of cells and of biological materials carry negative charges, thus two surfaces are 
repulsive in close proximity (29). Adhesion occurs because this repulsive force is 
counteracted and overcome by other attracting forces. This concept originates from 
the theory of Deijaguin, Landau, Verwey and Overbeek (DLVO theory) (30). In 
addition, molecular structures, such as pili of microbial cells also facilitate in breaking 
this repulsive force due to the small radii of curvature of these structures (29). The 
forces involved in the phase one and the phase two of adhesion will be described. 
1.3.2.1 The phase one 
Movement of microbial cells is mainly under the influence of flow field of 
surrounding fluid at the distance of more than lOOnm from an adhering surface (31). 
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In addition, chemotaxis of microbial cells also contributed to the movement (32). 
The forces contributed in the phase one of adhesion are physicochemical 
and non specific in nature (33). These forces can be further classified into long range 
interactions and short range interactions (33). The long range interactions refer to the 
forces involved at the distance of 20nm — lOOnm between the cells and the adhering 
surface (31). Short range interactions refer to the forces involved at the distance of 
less than 20nm from the adhering surface (31). Mutual forces of van der Waals force, 
electrostatic forces, and hydrodynamic forces are involved in the long range 
interactions (31). Ionic bond, hydrogen bond, dipole interactions, and hydrophobic 
interactions are involved in the short range interactions (29). The repulsive force due 
to electric double layer between two adhering surfaces is also involved (29). Adhesion 
occurs when the interactions of these forces result in a decrease in the Gibb's free 
energy of the system (30). It is depicted by the equation of Extended DLVO theory: 
AGadh = AG 谓 + AG '^ + AGAB 
where Gadh is Gibb's free energy of adhesion, G^^^ is Gibb's free energy of van der 
Waals force, G'" is Gibb's free energy of electric double layer interactions, G^® is 
Gibb's free energy of acid-base interactions, which represents interactions such as 
hydration, and hydrophobic interactions. 
The phase one of adhesion is influenced by factors changing the physical 
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properties of the two adhering surfaces as non specific physicochemical forces 
dominate in this phase. These factors include the hydrophobicity of two adhering 
surfaces (34), which in turn depending on the culture medium, surface charge of two 
adhering surfaces, temperature of the surrounding fluids, and concentration of 
electrolytes in the surrounding fluids (28). The list of the factors is not exhaustive. 
1.3.2.2 The phase two 
Molecular and cellular interactions between the molecular structures of 
two adhering surfaces contribute to the phase two of adhesion (33)，resulting in a firm 
adhesion of microbial cells. The molecular structures involved are the adhesins in 
fimbriae, pili, capsule, and slime (33). The F7i, F8, and F13 adhesins of fimbriated 
Escherichia coli (33)，capsular polysaccharide adhesin PS/A, and slime associated 
antigen (SAA) of Staphylococcus epidermidis were found to mediate adhesion (30). 
Microbial cells secrete adhesive extracellular matrix to the surface (35). This is 
especially important to adhesion to inanimate surfaces. As interactions between 
ligands and receptors dominate in this phase, the factors affecting this phase include 
the density and accessibility of ligands and receptors (36). 
1.4 Catheters 
Different types of catheter are used for the access of arteries, veins, urinary 
system, and central nervous system. Indwelling urinary catheters and intravenous 
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catheters are the most commonly used catheters. Indwelling urinary catheters or Foley 
catheters are inserted into urinary bladder for the drainage of urine. The catheters 
usually are made of latex or silicone (34). 
Intravenous catheters are further classified into PVC and CVC (33, 37). 
Peripheral intravenous catheters are usually inserted into metacarpal vein, dorsal 
venous arch, cephalic vein or basilic vein (38). The size of peripheral intravenous 
catheters ranges from 14 gauge to 22 gauge (38). These catheters are made of 
polyurethane, or in older times, polyvinyl chloride or Teflon®. Central venous 
catheters are further divided into peripherally inserted central catheters, tunneled 
central venous catheters, non tunneled central venous catheters, and implantable ports 
(33，39). Central venous catheters are made of silicone or polyurethane (40). 
Hydrophobicity is an important physical parameter of catheter materials. It 
influences the adhesion of microbial cells. Hydrophobicity is reflected by an water 
contact angle (41). The higher the value, the higher is the hydrophobicity. The water 
contact angle of FEP, polyurethane, and silicone is 78°, 108°, and 109° respectively 
(42). 
1.5 Biology of Candida albicans 
1.5.1 Taxonomy of Candida albicans 
Candida albicans species is classified as phylum Ascomycota, class 
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Hemiascomycota, order Saccharomyces, family Candidaceae, and genus Candida 
(43). This classification scheme is based on the phylogentics study by comparing SSU 
rDNA sequences (44). Candida albicans species can be further classified into 
serotype A and serotype B according to the structure complexity of the mannan of cell 
wall mannoproteins (45，46). 
1.5.2 Morphology 
Candida albicans is a dimorphic yeast because it undergoes reversible 
yeast-mycelium transition (47，48, 49). However, it should be noted that its growth 
form is polymorphic (50, 51). It can grow in the forms of ovoid yeast cells, 
pseudohyphae, germ tubes, and hyphae. Yeast cells are unicellular and oval in shape 
with the size of about 3 x 5[im (47). It buds at the polar region of the cell. 
Pseudohyphae is a chain of the elongated yeast cells with constrictions at septa (49). 
Germ tube is the initial structure of the hyphae. It is a small elongated polar budding 
without constriction at septum. Hyphae is the filamentous growth form of Candida 
albicans. It arises from elongation instead of budding (48). Yeast cell formation is 
favored at temperature below 35°C and at pH 6.5 or below (47，52, 53). Germ tube 
formation takes place after 1-3 hours of incubation of yeast cells in serum at 37°C 
(54). Germ tube formation is also induced by 7V~acetylglucosamine，and L-proline 
(55). Further incubation in serum results in hyphae formation (49). Hyphae formation 
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is also favored at pH 6.5, by deficiency of nitrogen and carbon sources and a 
microaerobic environment (53). It should be noted that formation of hyphae requires 
the combination of all the factors stated above (48). 
1.5.3 Genome 
The genome of Candida albicans is diploid (56) of 32Mbp (57). It is 
comprised of 16 chromosomes designated as R, 1-7 in the order of the largest 
chromosome to the smallest (57). Candida albicans is reproduced by mitosis. Ploidy 
changes due to loss of chromosomes in mitosis were observed (59，60，61, 62’ 63). 
Only 60-70% of clinical isolates of Candida albicans possesses all of the 16 
chromosomes (64). 
Regions of intermediate repeat element called major repeat sequence 
(MRS) are present in the genome of Candida albicans. The MRS is comprised of a 
RPS region flanked by HOK and RB2 regions together. Their size is about 2 - 2.9kb, 
8kb, and 6kb respectively. The MRS is present in all chromosomes except 
chromosome 3 (57，58) although RB2 regions were found on chromosome 3. The 
size of these three elements, thus in turn, the size of the MRS varies from strain to 
strain (65, 66, 67). The MRS facilitates the translocation and deletion of 
chromosome fragments, resulting in genome variability and chromosome length 
polymorphism (68). 
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1.5.4 Biology of Candida albicans cell wall 
1.5.4.1 Constituting molecules of Candida albicans cell wall 
Candida albicans cell wall consists of p-glucan, chitin, proteins, 
mannoproteins, and lipids (69), accounting for 48 - 60%, 0.6 - 2.7%, 3 - 6%, 20 — 
23%, and 2% of cell wall dry weight respectively (70). The composition of the 
P-glucans, and mannoproteins are similar in the cell wall of yeast cells, germ tubes, 
and hyphae cells. The chitin content is 4-5 folds higher in hyphae cells. 
The P-l,3-glucan, and p-l,6-glucan are polymers of P-D-glucose 
molecules linked by P-l，3-glycosidic bond and P-l,6-glycosidic bond respectively. 
Chitin is an unbranched polymer of 7V-acetylglycosamine linked by P-l,4-glycosidic 
bond. Each p-l,3-glucan polymer consists of about 40-50 branches of P-l,3-glucan 
linked by |3-l’6-glycosidic bond. One to two chains of P-l,6-glycan are branched 
from each P-l,3-glycan polymer through P-l,4-glycosidic bond. Chitin is linked to 
the P-l,3-glucan through P-l,4-glycosidic bond or associated by hydrogen bond (71). 
The two P-glucans, together with chitin provide the rigidity of the cell shape and the 
non-reducing ends for the linkage of cell wall proteins and lipids to the cell wall. 
Mannoprotein is the protein linked with mannan by N- or 0-glycosylation 
(69). Mannan is a polymer of mannose linked by a-l,6-glycosidic bond. 
yV-glycosylated mannan links to the asparagine amino acid residues, "-glycosylated 
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mannan is highly branched and is classified into complex mannan structure, 
intermediate structure, and simple structure. Either a single mannose molecule or a 
short unbranched mannan polymer is linked to the serine or threonine amino acid 
residues of cell wall proteins in the 0-glycosylated mannan. 
1.5.4.2 Organization of Candida albicans cell wall 
There are two models describing the organization of Candida albicans cell 
wall. Candida albicans cell wall is either viewed as a layered structure of at least 5 
layers, depending on strains, growth forms, and culture media (47，56, 72) or as a 
three dimensional structure of (3-l，3-glucan polymers filled with proteins and lipids 
(73, 74，75). 
In the first model, Candida albicans cell wall consists of a layer of 
mannoproteins on the cell membrane, followed by a layer of p-glucan and chitin. 
The layer is stacked by a layer of P-glucan and another layer of mannoproteins. The 
outer layer contained appendages extending from the Candida albicans cell wall 
(47). These appendages are named as fimbriae. Each fimbria is made of 
mannoproteins with the size of about 66kDa, thus called MP66 (76, 77). 
In the second model, polymers of p-l，3-glucan form a three dimensional 
network on the cell membrane of Candida albicans. P-l,6-glucan and chitin 
polymers are linked to the network through covalent bond or associated by hydrogen 
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bond. Cell wall proteins are either linked to the non reducing ends of p-l,3-glucan of 
the network directly or to the network via |3-l,6-glucan by the 
glycosylphosphatidylinositol (GPI) anchor. Proteins linking to the P-l,3-glucan 
directly are called Pir-protein and the those linked through GPI anchor are called 
GPI-protiens. A group of GPI-proteins are called agglutinin-like sequence (Als) 
proteins, which possess adhesive function. 
1.6 Agglutinin like sequence gene family 
1.6.1 Gene structure of agglutinin like sequence genes 
There are eight members in the agglutinin like sequence {ALS) gene family, 
namely ALSl, ALS2, ALS3IALS8, ALS4, ALS5, ALS6, ALS7, and ALS9. It was 
discovered that ALS3 and ALS8 are the same gene. They localize on three of the eight 
chromosomes of Candida albicans (78). The ALSl, ALS2, ALS4, ALS5, and ALS9 
localize on the chromosome 6 (78，79，80，81). The ALS6 and the ALS7 localize on 
chromosome 3 (82). The ALS3 / ALS8 localizes on chromosome R (83). 
All ALS genes share a conserved three domains structure. All characterized 
ALS genes consist of a 5' domain, a tandem repeat domain of 108 base pair (bp), and a 
3' domain (78). ALS genes exhibit high degree of inter-strain variability in the length. 
Reference to Candida albicans strain SC5314 (ATCC® number: MYA-2876), which is 
one of the most characterized strains (78)，the length of different ALS genes ranges 
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from 3144 bp (ALS3 smaller allele) to 6897 bp (ALS7) (82). 
The length of the 5' domain ranges from 1299 bp to 1308 bp. The length of 
the tandem repeat is variable, depending on the number of tandem repeat unit of each 
ALS gene. The length of the 3’ domain is also variable, ranging from 879bp (ALS3) to 
4404bp (ALS7) (78). The 3' domain of ALS7 is the longest among the other ALS genes 
(78) because another tandem repeat of 15 bp is embedded in the 3’ domain of ALS7 
(82). The region was named as VASES region because the code for the amino acid 
sequence is VASES. 
1.6.2 Sequence similarity 
Each domain of the ALS genes shares a number of similar features 
although a high degree of inter allele and inter strain variability in the length of the 
genes is observed. 
The length of the 5' domain of all ALS genes ranges from 1299 bp to 1308 
bp (78)，displaying little differences in length. The 5' domain shows 55% - 85% of 
identical sequence across the ALS gene family (78，80，82). The sequence of 5' 
domain of ALS!，ALS3 / ALS8, and ALS5 shares 85% of identity (81，83). In addition, 
the 5 ‘ domains of all ALS genes possess no more than two TV-glycosylation site coding 
sequences (78，80，82). The percentage of codons codes for serine and threonine, 
which represents possible (9-glycosylation site, ranges from 25% - 31%. 
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The tandem repeat domains of ALSl to ALS4 can cross hybridize to that of 
ALSl (80). The tandem repeat domains of ALS5 to ALS7 can cross hybridize to that of 
ALS5 (82). 
The 3’ domains of all ALS genes have more A^-glycosylation site coding 
sequences, and higher percentage of serine and threonine coding codons than the 5, 
domains of all ALS genes. It ranges from three to six sites, except none is found in the 
3，domains oiALSS and ofALS6 (80，82). It ranges from 36% to 45%, compare to the 
25% - 31% of the 5，domains (80，82). A region coding for a GPI anchor addition site 
is found in the 3'domains of all ALS genes (78，80，81). The 3’ domains of ALS2 and 
ALS4 share 95% of sequence identity (80), while that oiALS6 and ALS7 share 93% of 
sequence identity (82). 
1.6.3 Sequence variability 
Sequence variability between different alleles and different strains is 
contributed by differences in the number of tandem repeat present in different alleles 
and in the length of the 3’ domains. 
The number of tandem repeat unit contributes to most of the inter allele 
and inter strain differences of each ALS gene (78). For example, Candida albicans 
strain SC5314 (ATCC® number: MYA-2876) is heterozygous fox ALS3 and ALS5. The 
larger ALS3 allele has twelve repeating units and the smaller ALS3 allele has nine 
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repeating units (84). ALSl exhibit inter strain differences in the number of tandem 
repeat unit. Three to seven of tandem repeat units were found in Candida albicans 
strain SB B311, V6, V6R，1177, 3153A, CAI 4，and ATCC 18804 (79). 
Sequence polymorphism is also observed. For example, there are 2.1% and 
2.9% of sequence differences in the 5' domain and the 3，domain of ALS5 between 
Candida albicans strain CAI and Candida albicans strain 1161 (81). Apart from 
sequence variability, some ALS genes are missing in some Candida albicans strains. 
For example, Candida albicans strains B311 and B792 do not have ALS5 (81). 
1.6.4 Expression of ALS genes 
Expression of ALS genes is found to be associated with different 
physiological conditions. ALSl was first thought to be expressed in hyphae of 
Candida albicans (79). It was later found that expression of ALSl is induced by 
unknown substance(s)，in RPMI 1640, and yeast peptone dextrose (YPD) broth (83). 
Expression of ALS3 is hyphae specific. Expression of ALS4 was detected in Candida 
albicans cells in mid-log phase (80). Candida albicans cells exhibit low level of ALS5 
expression in YPD medium. 
Expression of different ALS genes was also detected in vivo. In an 
experiment conducted by Cheng and associates, all ALS genes were detected in the 
RNA extracted from clinical vaginal fluid specimens by reverse transcriptase 
20 
polymerase chain reaction (RT-PCR) (85). The percentage of detection of all ALS 
genes in patients with vaginal candidiasis symptoms was ALSl: 86%, ALS2: 71%, 
ALS3: 57%, ALS4: 21%, ALS5: 21%, ALS6: W/o,ALS7: 21%, 3ndALS9: 64% (85). 
Inter strain variability in the expression level of ALS genes was observed. 
In an experiment conducted by Hoyer and associates, ALSl was not expressed in two 
Candida albicans strains grown in YPD medium (83). It was found that one (WO-1) 
of the two Candida albicans strains does not possess the promoter sequence of ALSl 
(83). The expression level of ALS3 in RMPI 1640 of Candida albicans strains 
SC5314 and 3153A was higher than that of strain 1177, B311, B792, and WO-1 in 
another example (83). 
1.6.5 The AIs proteins 
Als proteins localize evenly on the cell wall of Candida albicans cells. The 
proteins are linked to the cell wall of Candida albicans cells through P-1, 6-glucan by 
GPI anchor. The size of different non glycosylated Als proteins ranges from 117kDa 
to 245kDa, depending on the size of the ALS genes. However, as Als proteins are 
heavily glycosylated (78)，the size of the glycosylated proteins is several times higher. 
For example, the size of non-glycosylated Alsl protein is 125kDa, and the size of the 
glycosylated Alsl protein is 600 kDa (78). 
The N terminal domains of all Als proteins are relatively free of 
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glycosylation (78，79，80，82，83) and are hydrophobic. A secretory signal sequence of 
17 bp is found at the start of the N terminal of all Als proteins (78, 79, 80，82，83). 
The sequences contribute to the localization of Als proteins on the cell wall. In an 
experiment conducted by Hoyer and Hecht，Saccharomyces cerevisiae transformed 
with the 5' domain of ALSl secreted N terminal domain proteins in culture medium. 
Deletion of the sequence resulted in the loss of secretion of the N terminal domain 
proteins (80). This demonstrated the importance of this sequence in the localization of 
the proteins. The N terminal is postulated to be an immunoglobulin (78，81，86). This 
postulation is supported by the high percentage of antiparallel p-sheet structure and 
the low percentage of a-helix structure in Alsl protein (86) and in Als5 protein (81). 
This structure pattern is exhibited in the immunoglobulin domain of other proteins 
(81). In addition, seven hypervariable regions were found in the N terminal domain of 
Alsl protein (86). 
There is little information about the tandem repeat domain and the C 
terminal domain of Als proteins. It is known that both the tandem repeat domain and 
the C terminal domain are heavily N- and 0-glycosylated. In addition, it is known that 
the C terminal domain of Als proteins is hydrophobic and there are two GPI anchor 
addition site coding sequences in the 3'domain (78，80，81). 
1.6.6 Functions of Als proteins 
22 
It is postulated that Als proteins possess adhesive functions because of the 
similarity with the a-agglutinin of Saccharomyces cerevisiae (79), and the possible 
immunoglobulin like structure of the N terminal domain (78，81, 86). 
In an experiment conducted by Sheppard and associates, ALSl, ALS3, and 
ALS5 transformed Saccharomyces cerevisiae adhered to gelatin, fibronectin, laminin, 
vascular endothelial cells, and FaDu epithelial cells (86). ALS6 transformed 
Saccharomyces cerevisiae adhered to gelatin, and the ALS9 transformed 
Saccharomyces cerevisiae adhered to laminin. ALS7 transformed Saccharomyces 
cerevisiae showed no adherence to the substrata tested in that experiment. These 
proteins exhibited different substrate specificity. Although the ALSl, ALS3, and ALS5 
transformed Saccharomyces cerevisiae exhibited highest adherence to fibronectin, the 
adherence of ALS3 clone to gelatin was about 50% lower than that of the ALSl and 
the ALS5 clones. However, the adherence of ALSl and ALS5 clones to FaDu epithelial 
cells was 50% lower than that of ALS3 clone (86). In an experiment conducted by 
Gaur and Klotz, Als5 proteins adhered to fibronectin and laminin, which is consistent 
with the result of the experiment by Sheppard and associates, and to collagen IV (87). 
In another experiment conducted by Zhao and associates, Als2 protein and Als4 
protein adhered to vascular endothelial cells (88). Als2 protein also adhered to 
reconstituted human oral epithelial cells (89). The substrate specificity is associated 
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with the N terminal domain (86). 
The adherence of Als proteins is influenced by the number of the tandem 
repeat unit. In an experiment conducted by Oh and associates, it was found that the 
adherence of Als3 larger allele protein of Candida albicans, which possesses 12 
tandem repeat units, had a higher adherence than the Als3 smaller allele protein, 
which possesses 9 tandem repeat units to human umbilical vein endothelial cells and 
pharyngeal epithelial cells (85). 
In the same experiment, it was found that deletion of Als2 protein or Als4 
protein resulted in a reduction in germ tube formation. 
1.7 Adhesion assay 
Adhesion can be studied using high accuracy quantitative methods, 
relative quantitative methods, and semi-quantitative methods (90). High accuracy 
quantitative methods measure the absolute adhesive energy between two adhering 
surfaces. In this project, a semi-quantitative method measurement was used. As a 
result, only semi-quantitative methods will be discussed. 
Adhesion assay consists of an adhesion model and a quantitation system. 
An adhesion model mimics the adhesion process of microbial cells to other cells or 
inanimate objects in vitro with a washing process for removing non-adherent 
microbial cells from the adhering surface. The quantitation system is any method 
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measuring the number of microbial cells remained adherent after washing (28). 
1.7.1 Adhesion model 
There are two types of adhesion model, namely static model and dynamic 
model (90). The static model refers to any adhesion model which microbial cells in a 
static cell suspension are allowed to sediment on cells or a surface for a certain period 
of time before washing. The dynamic model refers to any adhesion model passing cell 
suspensions through devices such as a parallel plate chamber and a cylindrical 
channel at a known flow rate. Microbial cells were subjected to the shearing force due 
to the flow of cell suspensions (41). 
The advantage of a static model is the ease to perform adhesion 
experiment, and no special device is needed. However, the gravitational force 
dominates in the phase one of adhesion process and shearing forces due to blood flow, 
administration of drugs in intravenous catheters cannot be mimicked. The advantage 
of a dynamic model is that the effect of flow can be studied and controlled (41). 
However, special devices are needed and experiments are more difficult to be 
performed. 
Adherence of microbial cells is represented by the percentage of initial 
inoculum adhered on substratum surface. The percentage of initial inoculum is 
calculated by the formula: 
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Number of microbial cells adhered 
Percentage of initial inoculum = x 100% 
Number of cells in initial inoculum 
The use of percentage of initial inoculum as an indicator of adherence is to 
standardize the results with the number of cells in the initial inoculum since small 
variations in number of cells may exist between the inoculum of different sample or 
between different batches of experiments. The use of percentage to represent 
adherence can ensure any difference in adherence detected is due to the adhesion 
properties of the microbial cells tested, instead of the variations in the cell number. 
1.7.2 Factors affecting static adhesion model 
A number of factors have to be considered in performing static adhesion 
assay. The factors include the inoculum size of microbial cells, bathing fluid, and 
incubation time. The topology and chemical composition of catheters also affect the 
results of an adhesion assay when catheters are used as substrata (28). It should be 
noted that the factors stated above are not exhaustive. 
The inoculum size of microbial cells affects the probability of a cell 
adhering on to an adhering surface (33, 36). As the number of cells increases, the 
accessibility of an adhering surface to a cell decreases, and the surface may be 
saturated with microbial cells (33’ 36). The purpose of an adhesion assay has to be 
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considered in determining the inoculum size. It is recommended that 10^ to 10^ cells 
should be used in an adhesion assay studying events happened within five minutes to 
two hours after addition of microbial cells. For adhesion assay studying microbial 
cells proliferation after adhesion, 10 to 10^ cells should be used (28). 
Bathing fluid influences the result of an adhesion assay by two fold. First 
metal ions such as magnesium ions and calcium ions can promote microbial cells 
adhesion to adhering surfaces by bridging two negative adhering surfaces. Second, the 
surface hydrophobicity of microbial cell surfaces and catheter surfaces is also affected 
by electrolyte composition (91). 
The incubation time of adhesion assay ranged from 5 minutes to 24 hours 
(28). It is suggested that the incubation time for microbial cells to sediment on an 
adhering surface depends on the aim of adhesion assay (28). In adhesion assays aimed 
at studying initial event of adhesion, the incubation time should be 5 minutes to 2 
hours, while the incubation time should be 6 hours to 24 hours for adhesion assays 
focus on cell proliferation after adhesion. However, it should be noted that there is no 
absolute standard on the incubation time to be used in adhesion assays. 
Adherence of a strain of microbial cells in relative measurement is 
represented by the percentage of initial inoculum adherent on an adhering surface. As 
a result, the number of cells adherent on an adhering surface is a function of the 
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surface area (33，34). Minor differences in the microtopology or smoothness, and 
manipulations on adhering surfaces such as cutting of catheters introduce variations in 
catheter surface area. Additives are added in catheters materials during production of 
catheters (33, 34). The chemical nature and composition of these additives are usually 
commercial secrets and vary between manufacturers (34). These additives also 
introduce variations, which can hardly be controlled. 
1.7.3 Quantitation methods of adherent cells 
Quantitation methods of adherent cells on catheter surfaces include 
sonication and culture of detached cells, staining of adherent cells, ATP 
bioluminescence, direct observation using optical microscope or scanning electron 
microscope, enzyme linked immunosorbent assay (ELISA), radiolabeling, and 
counting of detached cells (28, 90). It should be noted that the above methods are not 
exhaustive. Only the first three methods will be introduced. 
1.7.3.1 Sonication 
Adherent cells on catheter surfaces are removed by sonicating and 
vortexing catheters submerged in PBS in sterile test tubes or bijou bottles. The 
number of cells in PBS is then determined by viable count. The advantage is that 
number of adherent cells on catheters of different length and shape can be measured 
by this method. However, adhered cells on catheter surfaces may remain on catheter 
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surfaces after sonication. In addition, sonication may also lead to cell disruption (28). 
Both lead to underestimation of count. Preliminary experiments for determining the 
optimal power and oscillation frequency is favorable. 
1.7.3.2 Staining methods 
Adherent cells on catheters are stained using safranin or trypan blue (92). 
The adherent cells are destained using sodium dodecyl sulfate (SDS) buffer. The 
absorbance of the SDS buffer is measured. The number of cells is determined using a 
standard curve of absorbance against number of cells. This method is easy and 
inexpensive (92). This method may over estimated the number of adherent cells as 
slime and extracellular matrix, which is not directly proportional to the number of 
cells, are also stained by safranin or trypan blue. 
1.7.3.3 ATP bioluminescence 
Catheter sections or fragments are placed in bioluminescence reagents for 
the extraction of ATP from cells and for bioluminescence reaction. Bioluminescence 
is measured. The number of cells is determined using standard curve of 
bioluminescence against number of cells. This method is more sensitive than staining 
method (28). However, it may over estimate the number of adherent cells as ATP from 
dead cells is extracted for bioluminescence reaction also. A standard curve should be 
prepared for each strain of microbial cells tested as the number of ATP molecules per 
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cell vary from strain to strain. 
1.8 Research model 
In this study, the adhesion properties of the ALS gene were studied using a 
Saccharomyces cerevisiae model. The ALS genes of Candida albicans were 
transformed into Saccharomyces cerevisiae and the adherence of the transformed 
Saccharomyces cerevisiae was measured. In effect, the functions of the ALS genes of 
Candida albicans were reflected by the functions of the ALS genes transformed into 
Saccharomyces cerevisiae. The results obtained in this study would only be valid if 
the Als proteins translated in Saccharomyces cerevisiae retain their native structures 
and functions as in Candida albicans cells. As in the use of other model organisms, 
this research model is based on the assumption that Candida albicans and 
Saccharomyces cerevisiae are the descents of a common ancestor and their metabolic, 
developmental pathways and genetics materials are largely conserved. As a result, the 
Als proteins translated in Saccharomyces cerevisiae should retain their native 
structures and functions. This is supported by the fact that Candida albicans and 
Saccharomyces cerevisiae belongs to the same order Saccharomyces and are close 
relatives (93). In addition, there are evidences suggesting that Candida albicans and 
Saccharomyces cerevisiae are largely conserved at the level of transcription (94) and 
the biosynthesis of GPI proteins (95), which Als protein is one of them. 
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In addition, the phenotypic effect of the model organism after genetic 
manipulations should be easily observed. In adhesion study, the adherence of the 
transformed ALS genes (or other genes) should not be masked by the basal adherence 
of the Saccharomyces cerevisiae itself. It was known that Saccharomyces cerevisiae 
possesses low level of adherence to a number of substrata such as fibronectin, human 
epithelial cells, and polystyrene (86，96，97). A number of adhesive genes were found 
in Saccharomyces cerevisiae including FLOl, FLOS, FL09’ FLOW, FLO 11, FIG2, 
and a-agglutinin (98，99，100). However, only FLO 11 conferred Saccharomyces 
cerevisiae adherence to agar and plastics (98)，while the others were responsible for 
the flocculation and mating of Saccharomyces cerevisiae cells, instead of conferring 
adherence to other substrata (98, 99，100) while a number of adhesive genes were 
found in Candida albicans including HWPl, EPA J, and different ALS genes (101). 
The low adherence of Saccharomyces cerevisiae to a number of substrata prevents the 
adherence of Als proteins from being masked. 
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Chapter 2 Aim of study 
The aim of this study is (i) to study the effect of inoculum size in an 
adhesion model of catheters and to establish a quantitation system for the adhesion 
model; and (ii) to study the effect of transformation of ALSl, ALS5 smaller allele, and 
ALS6 to Saccharomyces cerevisiae on its adhesion to human fibroblasts，and to 
tetrafluoroethylene and hexafloropropylene polymer (FEP), polyethylene, and silicone 
catheters. 
The effect of transformation of ALSl, ALS5 smaller allele, and ALS6 to 
Saccharomyces cerevisiae on its adherence to human fibroblasts and to FEP, 
polyurethane, and silicone catheters has never been reported. The study can provide 
additional information on the function of the three genes in adhesion. 
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Chapter 3 Materials and Methods 
3.1 Preparation of bacteriological reagents 
Phosphate buffered saline was prepared by dissolving 10 phosphate 
buffered saline (Dulbecco A) tablets (Oxoid, UK) in IL of double distilled water. The 
buffer was then autoclaved at 121°0, 103kPa for 15 minutes. Phosphate buffered 
saline was used for washing process in the culture of fibroblasts, Candida albicans 
cells, Saccharomyces cerevisiae cells and for the washing process in adhesion assays. 
Sabouraud dextrose agar (SDA), YPD agar and YPD broth were prepared 
for the culture of Candida albicans and of Saccharomyces cerevisiae. Sabouraud 
dextrose agar was prepared by dissolving 65g of sabouraud dextrose agar powder 
(Oxoid, UK) in IL of double distilled water. The agar was then autoclaved at 121°0, 
103kPa for 15 minutes. Yeast peptone dextrose agar was prepared by dissolving 65g 
of yeast peptone dextrose agar powder (Sigma, USA) in IL of double distilled water. 
The YPD agar was then autoclaved at 121°0, 103kPa for 15 minutes. Yeast peptone 
dextrose broth was prepared by dissolving 50g of yeast peptone dextrose broth 
powder (Sigma, USA) in IL of double distilled water. The dissolved powder was then 
autoclaved at 12It：，103kPa for 15 minutes. 
Commeal tween 80 agar and chromagar were prepared for confirmation of 
identity of Candida albicans and of Saccharomyces cerevisiae. Commeal tween 80 
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agar was prepared by dissolving 17g of commeal agar powder (Oxoid, UK) in IL of 
double distilled water. Ten milliliter of tween 80 (Sigma, USA) was added. The agar 
was boiled to dissolve. The commeal tween 80 agar was then autoclaved at 121 °C， 
103kPa for 15 minutes. Chromagar was prepared by dissolving 47.7g of 
CHROMagar™ Candida (CHROMagar，France) in IL of double distilled water. The 
dissolved agar was autoclaved at 121°。，103kPa for 15 minutes. 
Horse serum for germ tube test of Candida albicans and of Saccharomyces 
cerevisiae was purchased from Oxoid, UK. Biochemical tests of Candida albicans 
and of Saccharomyces cerevisiae were performed using API 20C Aux (Biomerieux, 
France). 
3.2 Confirmation of identity of Candida albicans and of Saccharomyces 
cerevisiae 
Identity of presumptive Candida albicans and of Saccharomyces 
cerevisiae was investigated by the morphology test on commeal agar, germ tube 
formation in horse serum, biochemical tests, and colony color on chromagar. 
Presumptive Candida albicans strain SC5314 (ATCC® number: MYA-2876) and 
presumptive Saccharomyces cerevisiae (ATCC® number: 96686) were cultured on 
SDA at 30°C for 48 hours. Isolated colonies on the SDA were used for the four tests 
stated above. 
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Morphology test on commeal agar was performed by incubating 
presumptive Candida albicans and presumptive Saccharomyces cerevisiae on 
commeal agar. The presence of the structure of hyphae, pseudohyphae, 
chlamydospores, and blastoconidia on the agar was used for the identification of 
Candida albicans and of Saccharomyces cerevisiae. Morphology test on commeal 
agar was performed by making a 1cm cut on the commeal agar surface. Then a single 
isolated colony of Candida albicans or of Saccharomyces cerevisiae was streaked 
across the cut perpendicularly. A flamed cover slip was placed over the inoculated 
region. The commeal agar was incubated at 30°C for 48 hours. Morphology of the 
Candida albicans and of Saccharomyces cerevisiae was observed using a light 
microscope. Clusters of blastoconidia located around the septa of hyphae, and single 
round chlamydospore at the terminal of hyphae should be observed for a Candida 
albicans culture (102). Large yeast cells of various shapes, absence of hyphae should 
be observed for a Saccharomyces cerevisiae culture (102). Scanty amount of short 
pseudohyphae may be observed. 
Germ tube test was performed by inoculating of presumptive Candida 
albicans and presumptive Saccharomyces cerevisiae in horse serum and incubated at 
37�C for 1 hour to 3 hours, followed by observation of germ tube formation under 
light microscope. Germ tube without constriction at the point of origin should be 
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observed for a Candida albicans culture. Germ tube-like structure with a constriction 
at the point of origin should be observed for a Candida tropicalis culture (102). Other 
microorganisms showing no germ tube should be considered as non Candida 
albicans. 
Biochemical tests (carbohydrate assimilation tests) of presumptive 
Candida albicans and of Saccharomyces cerevisiae were performed using 
commercially available packaged strips API 20C Aux (Biomerieux, France). The 
ability to assimilate D-glucose, glycerol, calcium 2-keto-gluconate, L-arabinose, 
D-xylose, adonitol, xylitol, D-galactose, inositol, D-sorbitol, 
methyl-aD-glucopyranoside, A^-acetyl-glucosamine, D-cellobiose, D-lactose, 
D-maltose, D-saccharose, D-trehalose, D-melezitose, and D-rafmose were tested. The 
assimilation pattern of a culture is represented by a profile index (97). The profile 
index is compared with the profile database of the company, giving the probability of 
different possible identities of the culture. 
Biochemical tests were performed by resuspending a single isolated 
colony of presumptive Candida albicans and presumptive Saccharomyces cervisiae in 
the suspension medium provided from the kit to 0.5 Mcfarland. The inoculum was 
added into the wells of two API testing strips. The strips with the culture chambers 
were incubated at 30°C for 72 hours. The turbidity of each well was recorded and the 
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profile index of the two cultures was calculated. The profile index was compare with 
the database. 
Colony color on chromagar was performed for identifying Candida 
albicans. Presumptive Candida albicans was cultured on a commercially available 
chromogenic agar. Metabolic enzymes of different yeasts metabolize the chromgenic 
substrates in the agar into products of different colors. The colony color of a Candida 
albicans culture should be green. The test was performed by streaking an isolated 
colony of the presumptive Candida albicans on a chromagar. The chromagar was 
incubated at 30°C for 48 hours. The color of the colonies was recorded. 
3.3 Cell culture of fibroblasts 
3.3.1 Preparation of cell culture reagents 
Minimum essential medium was prepared for the culture of fibroblasts. 
Trypsin-ethylenediaminetetraacetic acid (EDTA) was prepared for the trypsinisation 
of fibroblasts in subculture. 
Minimum essential medium was prepared by mixing 50mL of MEM lOX 
concentrate, 5mL of 200mM glutamine, lOmL of IM hepes，6mL of 7.5% sodium 
bicarbonate, 3mL of 4mg/mL gentamycin, and 50mL of bovine serum albumin with 
400mL of autoclaved double distilled water. All the cell culture reagents and 
chemicals were from Gibco, USA. Trypsin-EDTA for trypsinisation of fibroblasts was 
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prepared by mixing 1.25mL of 2% sodium-EDTA (Sigma, USA) with 2.5% trypsin 
solution (Sigma, USA). All the reagents were prepared in a class II biosafety cabinet. 
3.3.2 Recovery of freezing fibroblasts 
Fibroblasts (ATCC® number: CCL-171) was a deposit from the 
Department of Microbiology, the Chinese University of Hong Kong. The frozen stock 
was at the stage of passage. It was kept in the cryovial with ImL of minimum 
essential medium (MEM) (Gibco, USA) and supplemented with 5% of bovine serum 
albumin (Gibco, USA) and 5% of dimethyl sulfoxide (Sigma, USA). The cryovial 
was stored in liquid nitrogen. 
One milliliter of fibroblasts (ATCC® number: CCL-171) deposited in 
liquid nitrogen was defrosted at 37°C using a water bath. The fibroblasts were 
transferred into a 15mL centrifuge tube containing 5mL of MEM. The centrifuge tube 
was centrifuged at 5600rcf (relative centrifugal force) for 5 minutes at room 
temperature. The supernatant was removed. The pellet was resuspended in SmL of 
MEM in a T25 flask. The T25 flask was incubated at 37°C in 5% CO2 and 95% relative 
humidity (RH). 
3.3.3 Establishment of cell line 
The confluence of fibroblasts was checked after 72 hours. The fibroblasts 
would be further incubated for 24 hours if the confluence of fibroblasts was less than 
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90%. The fibroblasts would be subcultured to a T75 flask if attaining 90% of 
confluence. The MEM in the T25 flask was removed. The fibroblasts were washed 
twice with 5mL of PBS. Two milliliter of trypsin-EDTA was added into the flask and 
incubated at 37°C for 5 minutes. Complete dislodgement of fibroblasts was checked 
under an Eclipse TE 2000-S phase contrast microscope (Nikcon, USA). The 
fibroblasts were considered to be completely dislodged if all the fibroblasts were 
rounding off. The flask was slightly tapped if the fibroblasts were not completely 
dislodged. Three milliliter of MEM was added into the flask for stopping the action of 
trypsin. The cell suspension was centrifuged at 5600rcf for 5 minutes. The supernatant 
was removed. The pellet was resuspended in lOmL of MEM. The fibroblasts were 
incubated in a T75 flask at 37°C in 5% CO2 and 95% RH. The fibroblasts were passed 
to another T75 flask every two days. 
3.4 Preliminary study of adherence of Candida albicans to fibroblasts and 
to catheters 
3.4.1 Adherence to fibroblasts 
3.4.1.1 Preparation of fibroblasts 
The confluence of fibroblasts in a T75 flask was observed 48 hours after 
seeding. Fibroblasts would be further incubated for 24 hours if confluence was less 
than 80%. Fibroblasts would be harvested if 80% of confluence was attained. The 
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number of fibroblasts harvested was counted using a Fuchs-Rosenthal counting 
chamber. After counting, 2 x 10^ of fibroblasts were seeded in each well of two 6-well 
cell culture plates. The fibroblasts were cultured at 37°C in 5% CO2 and 95% RH for 
24 hours. The confluence of the fibroblasts was checked under a phase contrast 
microscope. The fibroblasts were further incubated for 24 hours if 100% confluence 
was not attained. The fibroblasts were used for adhesion assay of Candida albicans 
cells if 100% confluence of fibroblasts was attained. 
3.4.1.2 Preparation of culture of Candida albicans and of Saccharomyces 
cerevisiae 
Candida albicans strain SC5314 (ATCC® number: MYA-2876) and 
Saccharomyces cerevisiae (ATCC® number: 96686) were cultured on two YPD agar 
at 30°C for 48 hours. Single isolated colony of Candida albicans and of 
Saccharomyces cerevisiae was subcultured in two flasks of 30mL of YPD broth at 
30°C for 18 hours. Afterwards, the growth of the Candida albicans and of the 
Saccharomyces cerevisiae was measured by absorbance at 600nm. The optical density 
(OD) of two flasks of lOOmL fresh YPD broth was adjusted to 0.4 by adding an 
appropriate volume of the overnight Candida albicans cell suspension or 
Saccharomyces cerevisiae cell suspension. The volume of the two overnight cell 
suspensions added was calculated according to the following formula: 
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0.4 X lOOmL 
Volume of cell suspension needed = 
ODsoonm of ovcmight cell suspension 
The absorbance of the two flasks of fresh YPD broth was measured after the addition 
of the Candida albicans cell suspension or the Saccharomyces cerevisiae cell 
suspension for confirmation before incubation. The flasks were incubated at 30°C for 
3 hours. Afterwards, the absorbance of the two flasks of fresh YPD broth was 
measured. The Candida albicans cells and Saccharomyces cerevisiae cells in the two 
flasks of fresh YPD broth were considered to be in mid-log phase if the absorbance at 
600nm was between 0.8 and 1.0. The flasks were further incubated for 1 hour if the 
absorbance at 600nm was less than 0.8. The Candida albicans cells and the 
Saccharomyces cerevisiae cells in mid-log phase were centrifuged at 3528rcf for 5 
minutes. The supernatant was discarded. The pellets were washed twice with 5mL of 
PBS and then resuspended in 5mL of YPD broth. The two cell suspensions were 
placed on ice for maintaining Candida albicans cells and Saccharomyces cerevisiae 
cells in mid-log phase until the subsequent counting of Candida albicans and 
Saccharomyces cerevisiae cells was finished. The number of Candida albicans cells 
and of Saccharomyces cerevisiae cells in the YPD broth was measured using a 
Fuchs-Rosenthal counting chamber. The two cell suspensions were diluted with YPD 
broth to 300cell/mL. The cell concentration of the Candida albicans cell suspension 
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and that of Saccharomyces cerevisiae cell suspension was confirmed by spreading 
200|al of cell suspension on each of three SDA for each cell. The agar plates were 
incubated at 30°C for 48 hours. The number of colony forming unit (CFU) was 
counted. The Candida albicans cell suspension and the Saccharomyces cerevisiae cell 
suspension were used immediately for the subsequent adhesion assay. 
3.4.1.3 Adhesion assay 
One milliliter of the Candida albicans cell suspension was added to each 
of the three wells of a 6-well cell culture plate seeded with fibroblasts. One milliliter 
of the Saccharomyces cerevisiae cell suspension was added to each of the three wells 
of the 6-well cell culture plate. One milliliter of YPD broth was added to 3 control 
wells of another 6-well plate instead of adding cell suspension. The two cell culture 
plates were incubated at 37°C in 5% CO2 for 30 minutes. Afterwards, the cell 
suspensions and the broth were removed. The fibroblasts were washed with ImL of 
PBS twice. Six hundred microliter of trypsin- EDTA was added into each well for 
trypsinisation of the fibroblasts. The plates were incubated at 37°C in 5% CO2 and 
95% RH for 5 minutes. Two hundred microliter of the trypsin- EDTA was plated on 
each of 2 SDA (1 well 3 SDA). The residual trypsin- EDTA was plated on the last 
SDA. The SDA were incubated at 30°C for 48 hours. The CFU of each SDA was 
counted. The number of Candida albicans cells adhered on 1 well of fibroblasts was 
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the sum of the CFU of the 3 SDA of the well. The percentage of initial inoculum 
adhered on fibroblasts was calculated by the following formula: 
CFU adhered on fibroblasts 
Percentage of initial inoculum = x 100% 
CFU of initial inoculum 
Two independent experiments were conducted on two different days for confirming 
the results. 
3.4.2 Adherence to catheters 
3.4.2.1 Preparation of catheters 
Tetrafluoroethylene and hexafloropropylene polymer catheters were the 18 
G X 1.88 inch BD A n g i o c a t h T M peripheral venous catheter (1.3mm x 48mm) (Becton 
Dickinson, USA). Polyurethane catheters were the Leaderflex (Central venous 
catheter made of polyurethane. Catalogue number: 121.08，Vygon, France). Silicone 
catheters were the Lifecath (Silicone Central Venous Catheter with Dacron Cuff for 
Long Term Tunnelled Use. Catalogue number: 2193.96, Vygon, France). Twelve 1cm 
FEP catheters fragments, twelve 1cm polyurethane catheter fragments and six 1cm 
silicone catheter fragments were prepared using a pair of sterile scissors, ruler and a 
pair of sterile forceps in a class II biosafety cabinet. 
3.4.2.2 Adhesion assay 
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The catheter fragments were put into 30 sterile 5mL screw-capped glass 
bijou bottles, one catheter fragment per bijou bottle. Candida albicans cell suspension 
was prepared as described in Section 3.4.1.2 except that the Candida albicans cell 
suspension was diluted to IxlO^cell/mL instead of 300cell/mL. One milliliter of the 
Candida albicans cell suspension was added into 6 bijou bottles with FEP catheter 
fragments, 6 bijou bottles with polyurethane catheter fragments and 3 bijou bottles 
with silicone catheter fragments. One milliliter of YPD broth was added in each of the 
remaining bijou bottles as control. The bijou bottles were incubated at 37°C in 5% 
CO2 with the caps loosened for 30 minutes. Afterwards, the catheter fragments were 
transferred aseptically into 30 new sterile 5mL screw capped glass bijou bottles, one 
catheter fragment per bijou bottle. The catheter fragments were washed with ImL of 
PBS twice. Three of each type of catheter fragments incubated in Candida albicans 
cells suspensions and three of each type of catheter fragments incubated in YPD broth 
were transferred into 18 new sterile 5mL screw capped glass bijou bottles, one 
catheter fragment per bijou bottle. Three milliliter of YPD broth was added to each of 
the 18 bijou bottles. The bijou bottles with catheter fragments and the control bijou 
bottles were incubated at 30°C for 24 hours. The turbidity of the YPD broth was 
compared visually. Candida albicans cells were considered to be adhering on the 
catheter fragments if the YPD broth was turbid. Candida albicans cells were 
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considered to be not adhering on the catheter fragments if the YPD broth was clear. 
For the remaining catheter fragments, one milliliter of methanol was added 
into each bijou bottle for 2 minutes at room temperature. Then the methanol was 
aspirated. The catheter fragments were air-dried at room temperature for 5 minutes by 
removing the caps of bijou bottles. The bijou bottles were covered by filter paper for 
preventing the catheter fragments from contamination of microorganisms from 
environment. One milliliter of acridine orange was added to each bijou bottle for 2 
minutes. Acridine orange stain was prepared by dissolving 20mg of acridine orange 
powder (Sigma, USA) in 190mL of IM sodium acetate solution (98). Then the 
acridine orange was aspirated. The catheter fragments were washed with ImL of PBS 
twice and air dried as described above. Catheter fragments surface were observed for 
the presence of orange spots using a Leitz Laborlux 12 phase contrast darkfield 
microscope (Leica, Germany). Presence of orange spots on catheter surface was 
considered to be adhered Candida albicans cells. Silicone catheter was not tested for 
acridine orange staining because silicone catheter was opaque. The adherence of 
Candida albicans cells to silicone catheter fragments was tested by the turbidity test 
only. 
3.5 Confirmation of expression of ALSl, ALS5 smaller allele, and ALS6 of 
Candida albicans in YPD broth 
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3.5.1 RNA extraction of Candida albicans 
Culture of Candida albicans strain SC5314 (ATCC® number MYA-2876) 
was prepared as described in Section 3.4.1.2 except that the cell suspension was 
diluted with YPD broth to IxlO^cell/mL and Saccharomyces cerevisiae was not 
cultured. One milliliter of Candida albicans culture in YPD broth was centrifuged at 
1209rcf for 5 minutes. The pellet was washed with ImL of PBS twice. The pellet was 
resuspended in 100|j.l of Buffer Y1 in a 1.5mL microcentrifuge tube for digesting the 
cell wall. Buffer Y1 was prepared by dissolving 18.22g of sorbital (Sigma, USA) and 
2.92g of EDTA (Pharmacia, USA) in lOOmL of autoclaved double distilled water. 
Lyticase (Sigma, USA) at the concentration of SOU per 1x10^ Candida albicans cells 
and 0.1% of P-mercaptoethanol (Merck, Germany) were added into Buffer Y1 just 
before use. The tube was incubated at 30°C using a water bath for 30 minutes. RNA 
was extracted after lysis of cell wall using RNeasy Mini Kit (Qiagen, USA) according 
to the instructions of manufacturer. Briefly, 350|al of Buffer RLT was added for the 
lysis of the spheroplasts. The tube was vortex at the top speed of a Maxi Mix II Vortex 
Mixer (Thermolyne, USA) for 10 seconds. Then 250|il of 96% ethanol (Beijing 
Reagent, China) was added. The solution was transferred to a spin column provided. 
The column was centrifuged at 22,713rcf for 15 seconds using the same centrifuge. 
Then 700}a.l of Buffer RWl was added to the spin column. The column was 
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centrifuged at 22,713rcf for 15 seconds. Then 500|al of Buffer RPE was added to the 
column. The column was centrifuged at 22,713rcf for 15 seconds. Then 500|il of 
Buffer RPE was added to the column. The column was centrifuged at 22,713rcf for 2 
minutes using the same centrifuge. The RNA was eluted in 30|il of Ultrapure distilled 
water at 72°C (Gibco, USA). The RNA was stored at -80°C. 
3.5.2 RT-PCR of ALSl，ALS5 smaller allele, and ALS6 
3.5.2.1 Primers 
Primers were designed using software GeneTooF^ (BioTools, Canada). 
The primers were designed according to the following criteria. First, the forward and 
reverse primers of each gene started from the two termini of the corresponding gene. 
Second, the length of the primers was not higher than 25 bases apart from the 
sequences of restriction digestion sites added and the capping sequences ahead of the 
restriction sites. Restriction digestion sites were added because the primers designed 
would be used in the polymerase chain reaction (PCR) of the three ALS genes. Third, 
the difference in the melting temperature (Tm) of the two primers of each gene was 
not higher than 5°C. Fourth, no false priming to other region of the gene was 
exhibited. Fifth, no significant alignment with other genes of Candida albicans was 
exhibited. The alignment of the primers with other genes of Candida albicans was 
performed using nucleotide-nucleotide blast program (blastn) of National Center for 
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Biotechnology Information (NCBI). The accession number of ALSl of Candida 
albicans strain SC5314 (ATCC® number: MYA-2876) was XM_712984 XM—436303, 
ALS5 smaller allele sequence was AY227439, and ALS6 sequence was AY225310. 
The ALSl was amplified using forward primer 
5'-TAGGGCGGATCCCATGCTTCAACAATTTACATT-3' and reverse primer 
5 ‘ -TAGGGCGCGGCCGCTCACTAAATGAACAAGGACA-3 ‘. ALS5 smaller allele 
was amplified using forward primer of ALSl and reverse primer 
5 ‘-TAGGGCCGGCCGTCATAGAAAGAAGAATAA-3 ‘. ALS6 was amplified using 
forward primer 5 ‘ -TAGGGCCGGCCGATG AAGAC AGTAATACTATT-3 ‘ and 
reverse primer 5 ‘ -TAGGGCTCTAG ATC ATA AG AAG A AGAATA AT-3 ‘. All the 
primers were purchased from Invitrogen, USA. Each of the primer powders was 
dissolved in Ultrapure Distilled Water (Gibco, USA) to the concentration of lOOjiM. 
Five microliter of forward primer and 5|il of reverse primer were mixed in 90|j1 of 
Ultrapure Distilled Water (Gibco, USA) as working stock (lO^M). 
3.5.2.2 RT-PCR 
Each RT-PCR reaction consisted of 10|il of 2X buffer of SuperScript III 
One Step RT-PCR Platinum Tag high fidelity (Invitrogen, USA), containing 3.2mM of 
magnesium chloride and 400|xM of dNTP, of 10|iM primers, of enzyme mix, 
0.5|j.l of RNA extracted from Candida albicans strain SC5314 (ATCC® number: 
48 
MYA-2876), and each reaction was made up to 20|il by Ultrapure Distilled water 
(Gibco, USA). Tetrad thermocycler (MJ research, USA) was preheated to 50°C before 
the start of RT-PCR. Reverse transcription of the three ALS genes were conducted at 
50°C for 30 minutes. The reactions were heated to 94°C for 2 minutes for inactivation 
of reverse transcriptase and for the activation of Tag polymerase. Thirty five cycles of 
PCR were performed using the following cycling parameters: 94°C of denaturation 
for 10 seconds, 56°C of annealing for 30 seconds and 68°C of extension for 5 minutes. 
The RT-PCR was completed after a final extension at 68°C for 15 minutes. 
The RT-PCR product of each gene was mixed with 4|il of loading dye and 
was loaded in a 1.5% agarose gel. The agarose gel was prepared by dissolving 3g of 
Agarose for separation > 500bp. Ultrapure, MB Grade (USB, USA) in 200mL ofTBE 
buffer of 0.5X strength. Tris-borate EDTA buffer was prepared by dissolving 33.73g 
of Tris-borate EDTA (USB, USA) in 200mL of double distilled water to formulate a 
lOX concentrate. Two hundred milliliter of the lOX concentrate was added into 
3800mL of double distilled water to formulate a 0.5X buffer. The agarose was boiled 
using a household microwave until completely dissolved. The gel was poured into a 
gel tray loaded with a gel comb. The length of each well was 0.5cm, the width was 
0.2cm, and the depth was 1cm. The gel was immersed in TBE buffer with 0.5X 
strength in a gel running tank. One microliter of Ikb trackit molecular marker 
49 
(Invitrogen, USA) was loaded into one of the well. Gel electrophoresis was performed 
at 120V for 1 hour. The agarose gel was stained with ethidium bromide for 30 minutes. 
The gel was observed under ultraviolet light. Photo record of the gel was taken. 
3.6 Establishment of quantitation system of adhesion assay 
Two detection methods for adhesion assay of Candida albicans cells and 
of Saccharomyces cerevisiae to catheters were tested in order to measure the number 
of cells adhered on catheters. The first method was the measurement of the 
absorbance of Candida albicans cells stained with safranin. Another method was the 
measurement of ATP bioluminescence of Candida albicans cells. Detection method 
having a broarder linear range and a lower detection limit was considered to be a 
more sensitive method and was adopted. 
3.6.1 Absorbance measurement of Candida albicans stained with safranin 
3.6.1.1 Preparation of Candida albicans culture 
Candida albicans strain SC5314 (ATCC® number: MYA-2876) culture 
was prepared as described in Section 3.4.1.2 except that the pellet was resuspended in 
5mL of RPMI medium 1640 (IX)，Liquid, with L-glutamine (Gibco, USA) instead of 
5mL of YPD broth. Saccharomyces cerevisiae was not cultured. The number of 
Candida albicans cells was counted using a Fuchs-Rosenthal counting chamber. The 
Candida albicans cell suspension was diluted with RPMI 1640 (Gibco, USA) to 
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1x10 cell/mL. One hundred microliter of the cell suspension was serially diluted with 
900^1 of RPMI 1640 (Gibco, USA) by every ten fold to IxlOcell/mL for the 
establishment of standard curve. 
Cell concentration of the cell suspensions prepared was confirmed by 
viable count. One hundred microliter of cell suspensions of cell concentration 
IxlO^cell/mL, IxloVell/mL, Ix loWl/mL, IxlO^cell/mL and IxlO^cell/mL was 
serially diluted with 900|j.l of PBS for 5, 4，3, 2 and 1 times respectively. One hundred 
microliter of the PBS diluted cell suspensions, and cell suspensions at the 
concentration of 1x10 cell/mL, 1x10 cell/mL, and IxlOcell/mL were spread on each 
of 3 SDA. The SDA were incubated at 30�C for 48 hours. The number of CFU on the 
agar was counted. The number of cells in cell suspensions at each cell concentration 
was calculated by the formula: 
Number of cells per milliliter = Number of CFU x Dilution Fold x 10 
The number of CFU was multiplied by the factor of ten because only lOOjil of cell 
suspension was spread on SDA. 
3.6.1.2 Staining of Candida albicans 
Four milliliter of the cell suspensions of different cell concentration was 
51 
added to each of the 3 wells of five 6-well cell culture plates (Becton Dickinson, 
USA). The plates were incubated at 37°C in 5% CO2 and 95% RH for 1 hour. 
Afterwards, the cell suspension in each well was removed to 27 sterile 5mL screw 
capped glass bijou bottles for subsequent viable count, 1 well per bottle. Each well 
was washed with ImL of PBS twice. The PBS was removed to another 54 sterile 5mL 
screw capped glass bijou bottles for subsequent viable count, 1 well per bottle. One 
milliliter of safranin was added to each well for 15 minutes at room temperature. 
Safranin stain was prepared by dissolving O.lg of safranin powder (Sigma, USA) in 
lOOmL of autoclaved double distilled water for staining the Candida albicans cells. 
The safranin was removed. The wells were washed with ImL of PBS twice. One 
milliliter of SDS buffer was added into each well for 30 minutes for destaining. 
Sodium dodecyl sulfate buffer was prepared by mixing O.lg of sodium dodecyl 
sulfate (Sigma, USA) in lOOmL of autoclaved double distilled water. Two hundred 
microliter of these SDS buffer from each well was added into each of the 3 wells of a 
96-well microtiter plate. The absorbance of the SDS buffer at 490nm was measured 
by OpsysMR 96-well microplate reader (Dynex, USA). 
3.6.1.3 Viable count of Candida albicans adhered on the 6-well plate 
The cell suspensions were transferred to bijou bottles after adhesion, and 
the PBS transferred to bijou bottles after washing were cultured on SDA for the 
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calculation of Candida albicans cells adhered on the cell culture plates. Three SDA 
were used for each removed cell suspension and each removed PBS in bijou bottles. 
One hundred microliter of the removed cell suspensions from each bijou bottle, and 
200^1 of the removed PBS from each bijou bottle was spread on each of 3 SDA. The 
SDA were incubated at 30°C for 48 hours. The number of CFU of each SDA was 
counted. The total number of cells present in cell suspensions after adhesion and in 
the PBS after washing was calculated proportionally. The number of cells adhered on 
the 6-well plate was determined by the following formula: 
number of cells in cell suspensions - number of cells in 
Number of cells adhered = cell suspensions after adhesion - number of cells in PBS 
after washing 
A graph of absorbance at 490nm against the number of cells adhered on 6-well plate 
was plotted for determination of the standard curve of this method. Two independent 
experiments were conducted on two different days for confirming the results. 
3.6.2 ATP bioluminescence 
Candida albicans cell suspensions of different concentrations were 
prepared as described in Section 3.6.1.1. One hundred microliter of the cell 
suspensions of different concentrations was added into each of 3 wells of an Opaque 
96-well flat bottom assay plate. (Becton Dickinson, USA). One hundred microliter of 
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RPMI 1640 was added into 3 wells as the background control of the ATP 
bioluminescence measurement. One hundred microliter of the buffer solution of 
BacTiter-Glo™ Microbial Cell Viability Assay (Promega, USA) containing luciferin 
as substrate and luciferase was added to each well. The plate was covered with 
aluminum foil at room temperature for preventing the plate from illumination. The 
ATP bioluminescence was measured by Micro Lumat Plus Luminometer (EG and G 
Berthold, Germany) 10 minutes later. A graph of bioluminescence against the number 
of cells was plotted for the determination of the linear range and the detection limit of 
this method. 
3.7 Effect of inoculum size on adhesion to catheters 
3.7.1 Preparation of adhesion chambers 
The adhesion chambers were made of lOg of high molecular weight 
agarose (USB, USA) dissolved in 200mL of double distilled water. The agarose was 
boiled using a household microwave oven until completely dissolved. Gel comb was 
loaded on a gel casting tray. The length of each well (adhesion chamber) was 0.5cm, 
the width was 0.3cm, and the depth was 1cm. The adhesion chambers were made on 
the day before the experiment to save time on the day of experiment. The whole gel 
tray was wrapped with parafilm, stored in a locally purchased plastic box at room 
temperature. The length of the box was 28cm, the width was 22cm, and the height 
54 
was 8cm. About 150mL of tap water was poured into the box for maintaining the 
humidity in the box. Two petri dishes were placed beneath the gel tray, preventing the 
gel tray from contacting the water. 
3.7.2 Preparation of catheters 
Tetrafluoroethylene and hexafloropropylene polymer catheters, 
polyurethane catheters, and silicone catheters were cut into 0.5cm fragments using a 
pair of sterile scissors, ruler and a pair of sterile forceps in a class II biosafety cabinet 
on the day before experiment to save time on the day of experiment. Twelve catheter 
fragments from each type of catheters were stored in 3 sterile plastic petri dishes at 
room temperature until use. These petri dishes were sealed with parafilm, wrapped by 
aluminum foil for preventing the catheter fragments from illumination. Catheter 
fragments were loaded into the adhesion chambers horizontally using a pair of sterile 
forceps in a class II biosafety cabinet just before the addition of Candida albicans cell 
suspensions. 
3.7.3 Preparation of Candida albicans culture 
Candida albicans culture was prepared as described in Section 3.4.1.2 
except Saccharomyces cerevisiae was not cultured and the Candida albicans cell 
suspension was diluted to 2xl0^cell/mL. One hundred microliter of the cell 
suspension was serially diluted with 900|il of YPD broth by every ten fold to 
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2xl0^cell/mL. 
The cell concentration of each cell suspension was confirmed by viable 
count. Fifty microliter of each cell suspension was diluted with 950|xl of PBS. One 
hundred microliter of the diluted cell suspensions of original cell concentration of 
2xl0^cell/mL, 2xl0^cell/mL, 2xl0^cell/mL, 2xl0^cell/mL, and 2xl0^cell/mL was 
further diluted serially in 900|xl of PBS for 5, 4, 3, 2 and 1 times. One hundred 
microliter of each PBS diluted cell suspension was spread on a SDA. Three SDA were 
used for each cell suspension. The SDA were incubated at 30°C for 48 hours. The 
number of CFU on SDA was counted. The cell concentration of each cell suspensions 
was calculated according to the following formula: 
Cell concentration (cell/mL) = Number of CFU on SDAx Dilution Fold x 10 
The factor of 10 was derived by the fact that only the cells from lOOfil of each ImL 
cell suspension was spread on SDA and subsequently counted. 
3.7.4 Adhesion assay 
After loading the catheter fragments in the adhesion chambers, 50|j,l of 
each Candida albicans cell suspension were added into the well of each type of 
catheters, three wells of each type of catheter for one suspension. Same volume of 
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YPD broth was added in 3 wells of each type of catheters as control of each type of 
catheter. The whole gel casting tray was wrapped by parafilm for preventing the 
evaporation of cell suspension during incubation. The adhesion chambers were 
incubated at 37°C in 5% CO2 for 30 minutes. Afterwards, catheter fragments were 
transferred aseptically in 36 new sterile 5mL screw capped glass bijou bottles, one 
catheter per bottle. The catheter fragments were washed with 200|il of PBS twice. The 
catheter fragments were placed into the wells of an opaque 96-well flat bottom plate. 
One hundred microliter of YPD broth was added to each well. 
One hundred microliter of each Candida albicans cell suspension were 
added into the wells of the opaque 96-well flat bottom plate (Becton Dickinson, USA), 
3 wells for one suspension, for the establishment of standard curve. One hundred 
microliter of YPD broth was added to 3 empty wells as the background control of the 
ATP bioluminescence measurement. One hundred microliter of the buffer solution 
containing luciferin as substrate and luciferase was added to each well with catheter 
fragments, to each well with the cell suspensions and to the background control wells. 
ATP bioluminescence measurement procedures were the same as described in Section 
3.6.2 except that the cell concentration of standard curve was ranged from 
2xl0^cell/mL to 2xl0^cell/mL instead of from IxlO^cell/mL to IxlOcell/mL. A graph 
of ATP bioluminescence against the number of cells was plotted for the establishment 
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of the standard curve. A line attaining the smallest sum of square of deviation was the 
line of best fit of the standard curve. The linear equation of the best fit line was 
determined by the following equation: 
y = mx + C 
where y is the ATP bioluminescence reading, x is the number of Candida albicans 
cells, m is the slope of the line of best fit, and C is the y-intercept of the line of best 
fit. 
The number of Candida albicans cells adhered on each catheter fragments 
was calculated according to the linear equation of the corresponding standard curve of 
each type of catheters. The percentage of adhesion was calculated by the following 
equation: 
Number of cells on catheter 
Percentage of adhesion = X 100% 
CFU of corresponding initial inoculum 
Two independent experiments were conducted on two different days for confirming 
the results. 
3.8 Transformation of Saccharomyces cerevisiae with ALSl, ALS5 smaller 
58 
allele, and ALS6 
3.8.1 DNA extraction of Candida albicans 
Candida albicans cells for DNA extraction was prepared as described in 
Section 3.5.1. The DNA of the cells was extracted by non-enzymatic lysis of Candida 
albicans cells and followed by protein precipitation by ammonium acetate and ethanol 
precipitation of DNA using MasterPure™ Yeast DNA Purification Kit (Epicentre, 
USA) according to manufacturer's instructions. Briefly, the pellet was resuspended in 
300p.l of Yeast Cell Lysis Solution. The microcentrifuge tube was incubated at 65°C 
using a water bath for 15 minutes for the lysis of Candida albicans cells. The tube 
was placed on ice for 15 minutes. Then 150|xl of MPC Protein Precipitation Reagent 
was added. The tube was vortex at the top speed of a Maxi Mix II Vortex Mixer 
(Thermolyne, USA) for 10 seconds. The tube was centrifuged at 22，713rcf for 10 
minutes using the same centrifuge as above for precipitating proteins. The supernatant 
was transferred to a new 1.5mL microcentrifuge tube. Then 500|j,l of isopropanol 
(Beijing Reagent, China) was added for precipitating DNA. The tube was centrifuged 
at 22,713rcf for 10 minutes using the same centrifuge for harvesting DNA pellet. The 
supernatant was removed. The pellet was washed with 500|il of 70% ethanol (Merck, 
Germany). The tube was centrifuged at 22，713rcf for 10 minutes using the same 
centrifuge. The supernatant was removed. The DNA was dissolved in 50|il of 
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Ultrapure Distilled Water (Gibco, USA) at 72°C. The DNA was stored at -20°C. 
Two microliter of the DNA extracted was pipetted into a quartz capillary 
tube (Amersham, USA) for measuring DNA concentration using GeneQuant 
RNA/DNA Calculator (Pharmacia, USA) at 260nm. DNA concentration of samples 
was calculated according to the formula: 
DNA concentration (ug/mL) = Absorbance at 260nm x 50 
3.8.2 PGR oiALSl, ALS5 smaller allele, and ALS6 
Each PCR consisted of 2\i\ of buffer of Platinum Tag High Fidelity 
polymerase (Invitrogen, USA), 0.8|xl of 50mM magnesium chloride, 2|il of 2mM 
dNTP mix (Amersham, USA), \[l\ of lOjxM primer mix, and 2\i\ of 2ng/|xl genomic 
DNA of Candida albicans strain SC5314 (ATCC® number: MYA-2876). Each PCR 
was made up to 20|il by Ultrapure Distilled Water (Gibco, USA). The reactions were 
heated to 94°C for 2 minutes for activation of Taq polymerase. Thirty five cycles of 
PCR were performed using the following cycling parameters: 94°C of denaturation 
for 10 seconds, 56°C of annealing for 30 seconds and 68°C of extension for 5 minutes. 
The PCR was completed after a final extension at 68°C for 15 minutes. Five PCR 
were conducted for each gene and were pooled together after PCR for subsequent 
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manipulations. 
Gel electrophoresis was performed as described in Section 3.5.2.2 except that 
lOOfxl of the PCR products of each ALS gene was mixed with 20)il of loading dye 
instead of mixing 20|xl of RT-PCR products of each ALS gene with 4|al of loading dye. 
3.8.3 Gel extraction 
Agarose gel embedding the PCR products of each ALS gene was cut. The 
PCR products were extracted using QIAquick Gel Extraction Kit (Qiagen, USA) 
according to the manufacturer's instructions. Briefly, the agarose gel embedded with 
DNA was excised and weighted in four l.SmL microcentrifuge tubes. One hundred 
microliter of sodium iodide containing Buffer QG was added to every lOOmg of gel in 
each tube for dissolving the gel. The tubes were incubated at 50°C using a water bath 
for 10 minutes. The solution was transferred to four of the spin columns provided. 
The columns were centrifuged at 22，713rcf for 1 minute. Then 500|xl of Buffer QG 
was added to each column for removing remaining agarose gel. The columns were 
centrifuged at 22,713rcf for 1 minute using the same centrifuge. Then 750)11 of Buffer 
PE was added to each column for washing the DNA recovered. The columns were 
centrifuged at 22，713rcf for 1 minute twice using the same centrifuge. PCR products 
were eluted in 40^1 of Ultrapure Distilled Water (Gibco, USA) at 72°C. The 
concentration of the eluted PCR products was measured as described in Section 3.8.1. 
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3.8.4 Restriction digestion of PCR products of ALS genes and cloning 
plasmids 
The restriction sites at the two termini of the PCR products of ALSl and 
the pYES6CT cloning plasmids (Invitrogen, USA) for ligating with ALSl were cut 
using BamH I and Not I (New England Biolabs, USA). ALS5 smaller allele, ALS6, 
and the cloning plasmids for ligating with ALS5 smaller allele, and ALS6 were cut 
using Xba I and Not I (New England Biolabs, USA). Restriction digestion reactions 
of ALSl’ and of pYES6CT cloning plasmid for ligating with ALSl consisted of 2pl of 
lOX NEBuffer 3，0.2^ 1 of lOOX bovine serum albumin, 2\i\ of BamH I，l^ il of Not I, 
10|j.l of purified ALSl PCR product or pYES6CT plasmid. Reactions were made up to 
20|il by Ultrapure Distilled Water (Gibco, USA). The restriction digestion reactions of 
ALS5 smaller allele, ALS6, and pYES6CT cloning plasmids for ligating with ALS5 
smaller allele, or ALS6 consisted of 2^1 of lOX NEBuffer 3，0.2|xl of lOOX bovine 
serum albumin, Ij^l of Not I’ 1.5|il of Xba I, lOjil of purified ALS5 smaller allele PCR 
product, purified ALS6 PCR product, or pYES6CT plasmid. Reactions were made up 
to 20\i\ with Ultrapure Distilled Water (Gibco, USA). 
The restriction digestions were conducted at 37°C for 24 hours. Gel 
electrophoresis of restriction digestion products were performed as described in 
Section 3.5.2.2 for purification except that a 1% agarose gel was used instead of a 
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1.5% agarose gel. Restriction digestion products were extracted from the gel as 
described in Section 3.8.3. Concentration of the restriction digestion products 
extracted was measured as described in Section 3.8.1. 
3.8.5 Ligation of ALSl, ALS5 smaller allele, ALS6 with pYES6CT cloning 
plasmids 
The number of mole of the restriction digested PCR products of each ALS 
gene and of the cloning plasmid was calculated according to the formula: 
Concentration of DNA (ng/|il) x Volume of DNA (|il) 
Number of mole (nmole)= 
Number of base of gene x 330 
The average molecular mass of nucleotide is 330 
Molar ratio of the PCR products of each ALS gene to the cloning plasmids in the 
ligation was 4:1. Ligation reactions were catalysed by T4 DNA ligase (New England 
Biolabs, USA). Ligation of ALSl and pYES6CT cloning plasmid consisted of 2|il of 
T4 DNA ligase buffer, l^il of T4 DNA ligase, 2[i\ of digested ALSl, l|il of BamH 
I-Not I digested pYES6CT plasmid. The reaction was made up to 20|il with Ultrapure 
Distilled Water (Gibco, USA). Ligation of ALS5 smaller allele, or ALS6 with 
pYES6CT cloning plasmid consisted of 2|al of T4 DNA ligase buffer, l^il of T4 DNA 
ligase, 2.36|j,l of digested ALS5 smaller allele or ALS6, \2\i\ of Not I-Xba I digested 
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pYES6CT plasmid. The reaction was made up to 20[l\ with Ultrapure Distilled Water 
(Gibco, USA). Ligation was performed at 16°C for 24 hours. 
3.8.6 Transformation of ligated plasmids into Escherichia coli 
Li gated plasmids were transformed into Escherichia coli of XL-10 Gold 
Ultracompetent Cells (Stratagene, USA) according to the instructions of the 
manufacturer. The Escherichia coli cells were derived from XL2-Blue strain. The 
genotype was Tef D(mcrA)183 D(mcrCB-hsdSMR-mrr)l 73 endAl supE44 thi-1 
recAl gyrA96 relAl lac Hte [F, pmAB lacfZDMlS TnlO (Tef) Amy CamT- Briefly, 
4|xl of P-mercaptoethanol provided in the kit was added to the Escherichia coli in each 
of three 1.5mL microcentrifuge tubes. The cells were placed on ice and were stirred 
every two minutes for five times. Two microliter of ligation products was added to the 
Escherichia coli. The cells were placed on ice for 30 minutes. The cells were heat 
shocked at 42°C for exactly 30 seconds and were placed on ice for 2 minutes 
immediately after heat shock. Nine hundred microliter of NZY+ broth was added to 
each tube of Escherichia coli. NZY+ broth was prepared by dissolving lOg of casein 
hydrolysate (Fluka, Switzerland), 5g of yeast extract (Sigma, USA), 5g of sodium 
chloride (Merck, Germany) in IL of double distilled water. The pH of the solution 
was adjusted to 7.5. The solution was autoclaved at 121°0, 103kPa for 15 minutes. 
The solution was mixed with 12.5mL of filter-sterile IM magnesium chloride (Sigma, 
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USA), 12.5mL of filter-sterile IM magnesium sulfate (Sigma, USA), and 20mL of 
filter-sterile 20% a-D-glucose (BDH, UK) aseptically. The tubes were incubated at 
37°C for 1 hour and shaked at 200r.p.m. One hundred microliter of the cells of each 
tube was plated on 3 LB agar with 50ug/mL ampicillin. Luria broth agar was prepared 
by dissolving 0.62g of luria broth base (Difco，USA), 0.8g of agar technical (Oxoid， 
UK) in 40mL of double distilled water. The agar was autoclaved at 121°0, 103kPa for 
15 minutes. Two milligram of ampicillin (Sigma, USA) was added when the 
autoclaved agar was cooled to about 50°C. The cells were cultured at 37°C for 24 
hours. 
3.8.7 Miniprep of plasmids 
Five isolated colonies of transformed Escherichia coli of each ALS gene 
was subcultured in 8mL of LB broth with 50ug/mL of ampicillin in fifteen 15mL 
centrifuge tubes at 37°C for 24 hours, 1 tube for a clone. The broth was centrifuged at 
2016rcf for 5 minutes. The pellets were washed with 5mL of PBS twice. The plasmids 
of the Escherichia coli were extracted using QIAprep Spin Miniprep Kit (Qiagen, 
USA) by alkaline lysis of Escherichia coli, followed by the binding of DNA on silica 
membrane in acidic pH solution according to the instructions of manufacturer. The 
DNA was eluted in low salt solution or water (104, 105). Briefly, for each clone, the 
pellet was resuspended in 250jil of Buffer PI of the kit and was transferred to a 1.5mL 
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microcentrifuge tube. Then 250|il of Buffer P2 was added and mixed by inverting the 
tube for 4 to 6 times. Then 350|il of Buffer N3 was added and mixed by inverting the 
tube for 4 to 6 times. The microcentrifuge tube was centrifuged at 22,713rcf for 10 
minutes. The supernatant was transferred to a spin column provided. The column was 
centrifuged at 22，713rcf for 30 seconds. Then 500|il of Buffer PB was added to the 
column. The column was centrifuged at 22，713rcf for 30 seconds. Then 750|xl of 
Buffer PE was added to the column. The column was centrifuged at 22,713rcf for 30 
seconds twice. The plasmids were eluted with SOjil of Ultrapure Distilled Water 
(Gibco, USA) at 72°C. The concentration of the plasmids extracted was measured as 
described in Section 3.8.1. The plasmids were stored at -20°C. 
3.8.8 DNA sequencing 
DNA sequencing primers of the three genes were designed using software 
GeneToolTM (BioTools, Canada). The primers were designed according to the 
following criteria. First the Tm of the primers was between 50°C to 60°C. Second, the 
distance between two successive sequencing primers of a gene was between 500 bases 
to 600 bases. Third, no false priming to other region of the gene was exhibited. 
The sequences of the primers were shown in Appendix 1. All the primers 
were purchased from Invitrogen, USA. Each of the primer powders was dissolved in 
Ultrapure Distilled Water (Gibco, USA) to the concentration of lOOj^ M. Ten microliter 
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of the primer was diluted in 90|il of Ultrapure Distilled Water (Gibco, USA) as 
working stock (lOjiM). 
DNA sequencing of the extracted plasmids was performed by Macrogen 
(South Korea) for confirming the sequences. Both of sense DNA strand and anti sense 
DNA strand of ALSl, ALS5 smaller allele, and ALS6 inserted into the plasmids were 
sequenced. The DNA sequences of the three ALS genes inserted into plasmids 
obtained by sequencing were aligned with the DNA sequences of the corresponding 
ALS gene sequence from GenBank of NCBI. Accession number of ALSl sequence 
was XM_712984 XM_436303, ALS5 smaller allele sequence was AY227439, ALS6 
seuqence was AY225310. 
Sequence variation found only on either sense DNA strand or anti sense 
DNA strand was considered to be a sequencing error. Sequence variation found on 
both strands was considered to be a true mutation. 
3.8.9 Transformation of Saccharomyces cerevisiae 
Saccharomyces cerevisiae cells (ATCC® number: 96686) were made 
competent by lithium cations (106) using S.c. Easy comp Transformation Kit 
(Invitrogen, USA) according to the instructions of manufacturer. Briefly, lOmL of 
Saccharomyces cerevisiae cells was cultured in YPD broth until mid log phase. The 
cells were harvested and were washed with lOmL of Solution I of the kit. The cells 
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were centrifuged at 33.6rcf for 5 minutes at room temperature. The supernatant was 
removed. The pellet was resuspended in ImL of Solution II of the kit. The cells were 
then competent and were used for transformation immediately. 
Saccharomyces cerevisiae cells were transformed with the extracted 
plasmids by polyethylene glycol (107) using S.c. Easy comp Transformation Kit 
(Invitrogen, USA) according to the instructions of manufacturer. Briefly, 5|il of the 
plasmids was added to SOjil of competent Saccharomyces cerevisiae for 
transformation. Five hundred microliter of Solution III of the kit was mixed with the 
cells and the plasmids by vortex with the top speed of a Maxi Mix II Vortex Mixer 
(Thermolyne, USA). The cells were incubated at 30�C using a water bath for 3 hours 
for transformation. The cells were vortexed every 15 minutes. Afterwards, the cells 
were centrifuged. Four hundred and fifty five microliter of the supernatant was 
removed. The pellets was resuspended in the residual fluid and spread on a yeast 
peptone dextrose agar with 25 |ig/mL of blasticidin (YPDB). The agar was prepared 
by adding ImL of 25mg/mL of blasticidin solution in IL of autoclaved YPD agar at 
about 50°C. Yeast peptone dextrose agar was prepared as described in Section 3.1. 
Blasticidin solution was prepared by dissolving 25mg of blasticidin S HCl (Invitrogen, 
USA) in ImL of Ultrapure Distilled Water (Gibco, USA). 
The agar was incubated at 30°C for 72 hours. The plates were sealed with 
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parafilm and were kept at 4�C for long term storage. A single isolated colony of 
transformed Saccharomyces cerevisiae of each of the three ALS genes was picked and 
subcultured on another 4 YPDB. ALSl, ALS5 smaller allele, ALS6’ or empty plasmid 
transformed Saccharomyces cerevisiae used in future experiments were picked from 
these plates (master plates). 
3.8.10 Detection of Alsl, Als5, and AIs6 proteins expression 
3.8.10.1 Preparation of cultures in SC synthetic medium 
Each Saccharomyces cerevisiae clone was picked from corresponding 
master plates and was subcultured on another 4 YPDB. The agar was cultured at 3 0 • 
for 48 hours. A single isolated colony of each of the 4 clones was subcultured in 50mL 
of SC synthetic medium with 2% glucose and 25)ag/mL blasticidin at 30°C for 48 
hours without shaking. The absorbance of the Saccharomyces cerevisiae cultures at 
600nm was measured. The OD of each of lOOmL of fresh SC synthetic medium with 
3% galactose and 25mg/mL blasticidin was adjusted to 0.4 by adding an appropriate 
volume of the overnight cultures. The volume of cell suspensions needed was 
calculated as described in Section3.4.1.2. The overnight culture of each clone was 
centrifuged at 3528rcf for 5 minutes. The supernatant was removed. The pellets were 
washed with 5mL of PBS twice before resuspended in lOOmL of SC synthetic 
medium with 3% galactose and 25fa,g/mL blasticidin. The SC synthetic medium with 
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3% galactose and 25mg/mL blasticidin was incubated at 30°C for 18 hours without 
shaking. 
3.8.10.2 Protein extraction 
The cells were centrifliged at 6272rcf for 5 minutes. The supernatant was 
removed. The pellets were resuspended in ImL of 1.14% ammonium carbonate. Fifty 
microliter of lOOmM phenylmethysulfunyl fluoride (PMSF) (Roche, USA) and 2^1 of 
p-mercaptoethanol (Merck, Germany) were added. The cells were transferred to 4 
glass test tubes. One millilitre of glass beads (Sigma, USA) was added to each of the 
test tubes. The top of the test tubes were wrapped with parafilm for prevention of 
spilling during vortex. The test tubes were vortexed at the top speed of a Maxi Mix II 
Vortex Mixer (Thermolyne, USA) for 1 minute and then placed in ice for 1 minute 
before another vortexing. The test tubes were vortexed for five times. The cell lysates 
were transferred to four 1.5mL microcentrifuge tubes and centrifuged at 1209rcf for 
10 minutes. The supernatant was removed. The pellets were washed with ImL of 
1.14% ammonium carbonate twice. The pellets were resuspended in ImL of 1.14% 
ammonium carbonate. Fifty microliter of lOOmM PMSF and 2[i\ of 
p-mercaptoethanol were added to prevent the proteins from degradation. The cell wall 
extracts were stored at -80°C. 
3.8.10.3 Dot blot of cell wall lysates 
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A piece of PVDF membrane (BioRad, USA) with the length of 10cm, and 
width of 7cm was soaked in 20mL of methanol until the membrane was transparent in 
a locally purchased plastic box. The length of the plastic box was 12cm, the width 
was 8cm, and the height was 3cm. The methanol was removed. The membrane was 
washed with lOmL of double distilled water. Ten milliliter of double distilled water 
was poured in another plastic box of the same size. The membrane was transferred to 
this plastic box. The double distilled water was added to prevent the membrane from 
drying before the dotting of cell wall extracts. Ten microliter of the cell wall extracts 
from the Saccharomyces cerevisiae cells transformed with ALSl, ALS5 smaller allele, 
and ALS6 was dotted on the PVDF membrane and air-dried. The membrane was 
soaked in lOmL of PBSTM and was shaked at lOOr.p.m. for one hour. The PBSTM 
was removed. The membrane was washed with lOmL of PBST and was shaked at 
lOOr.p.m. for 5 minutes. The washing step was repeated. The PBST was removed. The 
membrane was soaked in lOmL of PBSTM. Two microliter of anti-His antibody was 
added in the PBSTM. The membrane was shaked at lOOr.p.m. for 24 hours. The 
PBSTM with antibodies in it was removed. The membrane was washed with lOmL of 
PBST and was shaked at lOOr.p.m. for five minutes. The washing step was repeated. 
The membrane was transferred to a swan warp with the side added with cell wall 
extracts on top. One millilitre of Reagent 1 and ImL of Reagent 2 of ECL Western 
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Blotting Reagent (Amersham, USA) were mixed in a sterile 5mL screw capped glass 
bijou bottle. The mixed blotting reagent was applied over the surface of the membrane. 
The membrane was wrapped by the swan warp. The membrane and a medical 
imaging film (Fuji, Japan) were placed in a film holder together in a dark room for 
exposure for 20 minutes. The film was developed. 
3.9 Adhesion of transformed Saccharomyces cerevisiae to fibroblasts 
3.9.1 Preparation of fibroblasts and of Saccharomyces cerevisiae cultures 
The procedures of the preparation of fibroblasts substratum prepared as 
described in Section 3.4.1.1. 
The cultures of transformed Saccharomyces cerevisiae of ALSl, ALS5 
smaller allele, ALS6, and empty plasmid (as control) were prepared as described in 
Section 3.8.10.1 except that 15mL, instead of 50mL of SC synthetic medium with 2% 
glucose and 25|j,g/mL of blasticidin was used for the subculture of isolated colony of 
each clone, and 30mL, instead of lOOmL of SC synthetic medium with 3% galactose 
and 25|ag/mL of blasticidin was used for the subculture of Saccharomyces cerevisiae 
cells harvested from SC synthetic medium with 2% glucose and 25|j,g/mL of 
blasticidin. After 18 hours of incubation, the medium was centrifuged at 3528rcf for 5 
minutes. The pellets were washed with 5mL of PBS twice. The pellets were 
resuspended in 5mL of SC synthetic medium with 3% galactose. The number of 
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Saccharomyces cerevisiae cells in the medium was determined using a 
Fuchs-Rosenthal counting chamber. The cell suspensions were diluted to 300cell/mL 
with SC synthetic medium supplemented with 3% galactose. The inoculum size was 
confirmed by viable count. Two hundred microliter of the cell suspensions was spread 
on a SDA. Three SDA were used for one cell suspension. The SDA were incubated at 
30°C for 48 hours. The number of CFU on the SDA was counted. The number of 
Saccharomyces cerevisiae cells in ImL of the cell suspensions was calculated 
according to the following formula: 
Number of cells per mL = (Average of number of CFU on 3 SDA) x 5 
The factor of 5 was derived by the fact that only the cells in 200|xl of the ImL cell 
suspensions were counted. 
3.9.2 Adhesion assay 
The adhesion assay was conducted as described in Section 3.4.1.3 except 
cell suspensions of transformed Saccharomyces cerevisiae were used instead of 
Candida albicans cell suspension. 
3.10 Adhesion of transformed Saccharomyces cerevisiae to FEP, 
polyurethane, and silicone catheters 
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3.10.1 Preparation of catheters, adhesion chambers, and transformed 
Saccharomyces cerevisiae cultures 
Catheter fragments and adhesion chambers were prepared as described in 
Section 3.7.1 and Section 3.7.2. 
Saccharomyces cerevisiae cultures of each clone were prepared as 
described in Section 3.9.1 except that the cell suspensions of each clone were diluted 
to 2xl0^cell/mL with SC synthetic medium with 3% galactose. 
One hundred microliter of the Saccharomyces cerevisiae cell suspensions 
of each clone was serially diluted with 900|al of SC synthetic medium with 3% 
galactose by every ten fold to 2xl0cell/mL for the establishment of standard curve. 
The cell concentration of each diluted cell suspension was confirmed by viable count. 
The viable count was conducted as described in Section 3.7.3 except that viable count 
of cell suspension at concentration of 2xl0^cell/mL was not performed. 
3.10.2 Adhesion to catheter fragments 
The adhesion assay was conducted as described in Section 3.7.4 except 
fifty microliter of the 2xl0^cell/mL culture of each transformed Saccharomyces 
cerevisiae (total 1x10^ cells) were added instead of Candida albicans cell suspensions. 
And same volume of SC synthetic medium with 3% galactose was added in 3 well of 
each type of catheters as control, instead of using YPD broth as control. ATP 
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measurement procedures were the same as described in Section 3.7.4 except that 
measurement of cell suspension at the concentration of 2xl0^cell/mL was not 
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performed. The standard curve was ranged from 2x10 cell/mL to 2xl0cell/mL. 
3.11 Statistical analysis 
All the statistical analysis was performed using Statistical Package for 
Social Sciences 14.0 for Windows (SPSS inc, USA). Mann-Whitney U test was used 
to compare the percentage of adherence of Candida albicans and Saccharomyces 
cerevisiae towards fibroblasts. Nonparametric ANOVA, Kruskal-Wallis test was used 
for comparing the result of percentage of adherence of Candida albicans towards 
catheters at different cell concentrations, and to compare the percentage of adherence 
of Saccharomyces cerevisiae transformed with different ALS genes towards 
fibroblasts and to catheters. 
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Chapter 4: Results 
4.1 Confirmation of identity of Candida albicans and of Saccharomyces 
cerevisiae 
The identity of presumptive Candida albicans was confirmed by 
morphology test on commeal agar, germ tube test, biochemical tests (carbohydrate 
assimilation tests), and coloration of colony on chromogenic agar. The identity of 
presumptive Saccharomyces cerevisiae was confirmed using the methods stated above 
except the coloration of colony. 
4.1.1 Candida albicans 
In the morphology test on commeal agar, hyphae was observed. Clusters 
of blastoconidia at the septa of hyphae, and single chlamydospore at the terminus of 
hyphae were observed. In the germ tube test, germ tubes extending from oval yeast 
cells without constriction at point of origin were observed after incubation of Candida 
albicans in serum for 2 hours at 37°C. In biochemical tests, the profile index obtained 
indicates 99.4% probability of the yeast being a Candida albicans. In the coloration of 
colony test, the coloration of colony of the yeast was green. 
4.1.2 Saccharomyces cerevisiae 
In the morphology test on commeal agar, large blastoconidia with few 
pseudohyphae were observed on commeal agar. No hyphae or chlamydospore was 
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observed on commeal agar. In the germ tube test, no germ tube was observed after 
incubation in serum for 3 hours at 37°C. In biochemical tests (carbohydrate 
assimilation tests), the profile index indicated 99.3% probability of the yeast being 
a Saccharomyces cerevisiae. 
4.2 Cell culture of fibroblasts 
The morphology and confluence level of fibroblasts cultured in T25 culture 
flask after recovery was checked after incubation at 37°C in 5% CO2 and 95% RH for 
72 hours. A monolayer of fibroblasts of 90% confluence was observed. Spindle-like 
structures extending from cell were observed from each cell (Figure la). This 
morphology was similar to the morphology of the fibroblasts described by ATCC 
(Figures.lb). As the recovered fibroblasts attained 90% confluence after incubation at 
37°C in 5% CO2 and 95% RH for 72 hours, the fibroblasts were subcultured into a T75 
culture flask for establishment of cell line. 
4.3 Preliminary studies of adherence of Candida albicans to fibroblasts and 
to FEP, polyurethane, and silicone catheters 
4.3.1 Adherence to fibroblasts 
The confluence of fibroblasts cultured in a T75 culture flask was checked 
after incubation at 37°C in 5% CO2 and 95% RH for 48 hours. A monolayer of 
fibroblasts of 80% confluence was observed. The fibroblasts were harvested and 
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counted. After counting, 2x10^ cells were seeded in each well of two 6-well plates. 
The confluence of fibroblasts cultured in each well of the two culture plates was 
checked. A monolayer of fibroblasts of 100% confluence was observed (Figure 2). 
The cells were used as substratum for preliminary adhesion assay of Candida albicans 
to fibroblasts. 
The adherence of Candida albicans strain SC5314 (ATCC® number: 
MYA-2876) was compared with that of Saccharomyces cerevisiae, which was known 
to be non adherent. The adherence of Candida albicans and that of Saccharomyces 
cerevisiae was represented by percentage of initial inoculum adhered on fibroblasts. 
The percentage of initial inoculum of Saccharomyces cerevisiae adhered to fibroblasts 
was 0.29%. The percentage of initial inoculum of Candida albicans adhered to 
fibroblasts was 6.40% (Figure 3). The statistical significance of the difference in the 
percentage of initial inoculum was tested by Mann-Whitney U test. The difference 
was statistically significant with p value = 0.04. 
4,3.2 Adherence to catheters 
Adherence of Candida albicans strain SC5314 (ATCC® number: 
MYA-2876) to FEP, polyurethane, and silicone catheter fragments were studied by the 
turbidity of YPD broth culturing catheter fragments after adhesion of Candida 
albicans and by the observation of catheter fragments, except silicone catheter 
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fragments , stained with acridine orange, using a phase contrast microscope darkfield 
microscope after adhesion of Candida albicans. 
The turbidity of YPD broth culturing the FEP, polyurethane, and silicone 
catheter fragments after adhesion of Candida albicans was compared visually with 
that of YPD broth culturing the catheter fragments of the control group. The YPD 
broth culturing the FEP, polyurethane, and silicone catheter fragments after adhesion 
of Candida albicans was more turbid than those of the control group (Table 1). 
Green fluorescence was observed on the surface of FEP catheter fragments 
of the control group. Green fluorescence was not observed on the surface of FEP 
catheter fragments after adhesion of Candida albicans. Orange spots were observed 
on the surface of FEP catheter fragments after adhesion of Candida albicans. 
Green fluorescence was observed on the surface of polyurethane catheter 
fragments of the control group. Green fluorescence was observed on the surface of 
polyurethane catheter fragments after adhesion of Candida albicans. Yellow spots 
were observed on the surface of polyurethane catheter fragments (Figrue 4). 
4.4 Confirmation of expression of ALSl’ ALS5 smaller allele, and ALS6 of 
Candida albicans in YPD broth 
Expression of ALSl, ALS5 smaller allele, and ALS6 in Candida albicans 
strain SC5314 (ATCC® number: MYA-2876) cultured in YPD broth was confirmed by 
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RT-PCR using RNA extracted from cells oi Candida albicans strain SC5314 (ATCC® 
number: MYA-2876) cultured in YPD broth. The coding DNA (cDNA) products were 
loaded into an agarose gel for gel electrophoresis. No cDNA product was present in 
the negative control of RT-PCR reactions of the three ALS genes. No PCR product 
was present in the PCR reaction of the three ALS genes using the extracted RNA as 
template. Coding DNA products were observed in the RT-PCR reactions of the three 
ALS genes (Figure 5). 
4.5 Establishment of quantitation system of adhesion assay 
4.5.1 Absorbance measurement of Candida albicans stained with safranin 
From the plot of absorbance of SDS buffer against cell number (Figure 6)， 
the background absorbance of the SDS buffer was 0.269. The absorbance reading in 
the range of 1 cell to IxlO* cells fluctuated between 0.241 and 0.301. The absorbance 
readings were not differentiable in this range. The absorbance reading increased from 
lxl04 cells. The absorbance reading at IxlO*，1x10^  and 4x10^ cells was 0.27，0.37， 
and 0.42 respectively. The absorbance reading increased at a higher rate from 4x10^ 
cells to 1x10 cells. The absorbance reading at 1x10 cells was 0.96. The linear range 
was between 4x10^ cells to 1x10? cells 
4.5.2 ATP bioluminescence 
From the plot of log (signal to noise ratio) against log (cell number) 
80 
(Figure 7)，the log (signal to noise ratio) increased from 1x10 to 1x10) cells at a 
slower rate. The log (signal to noise ratio) of 1x10，1x10^ , and 1x10^ cells was 0，0.61, 
and 0.60 respectively. The log (signal to noise ratio) increased at a faster rate from 
1x10^ to 1x10? cells. The log (signal to noise ratio) of IxlC^ IxlO�’ lxl06，and IxlO? 
cells was 1.32, 2.19, 3.25, and 4.10 respectively. The log (signal to noise ratio) 
dropped to 3.71 at 1x10^ cells. The log (signal to noise ratio) value of the detection 
limit of the ATP bioluminescence assay was set to be two standard deviation(background) 
above the background. The log (signal to noise ratio) value of the detection limit was 
1.3, corresponding to IxlO* cells. 
4.6 Effect of inoculum size on adhesion to catheters 
The effect of inoculum size on adhesion to FEP, polyurethane, and silicone 
catheter fragments was tested using 1x10^, 1x1 (A and 1x10^ cells of Candida 
albicans strain SC5314 (ATCC® number: MYA-2876). The adherence of Candida 
albicans to catheter fragments was represented by percentage of initial inoculum 
adhered to catheters. A graph of percentage of initial inoculum adhered to catheter 
against log (number of cells) of each catheter was plotted (Figure 8). 
The percentage of initial inoculum of Candida albicans adhered to FEP 
catheter fragments decreased as the cell number increased. The percentage of initial 
inoculum of Candida albicans adhered to FEP catheter fragments at 1x10^, 1x10^, and 
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1x10^ cells was 1.66%, 0.51%, and 0.24% respectively. The statistical significance of 
the difference in percentage of initial inoculum was tested by non parametric ANOVA, 
Kruskal-Wallis test. The p value was 0.113 and the difference was not statistically 
significant. 
The percentage of initial inoculum of Candida albicans adhered to 
polyurethane catheter fragments at 1x10^ 1x10^ and 1x10^ cells was 0.76%, 0.23%, 
and 0.31% respectively. The statistical significance of the difference in percentage of 
initial inoculum was tested by non parametric ANOVA, Kruskal-Wallis test. The p 
value was 0.193 and the difference was not statistically significant. 
The percentage of initial inoculum of Candida albicans adhered to silicone 
catheter fragments decreased as the cell number increased. The percentage of initial 
inoculum of Candida albicans adhered to silicone catheter fragments at 1x1 O^，1x1 
and 1x107 cells was 2.45%, 1.34%, and 0.51% respectively. The statistical 
significance of the difference in percentage of initial inoculum was tested by non 
parametric ANOVA, Kruskal-Wallis test. The p value was 0.177 and the difference 
was not statistically significant. 
4.7 Transformation of Saccharomyces cerevisiae with ALSl, ALS5 smaller 
allele, and ALS6 
4.7.1 PCR of ALSl, ALS5 smaller allele, and ALS6 
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The three ALS genes were first amplified from the genomic DNA of the 
Candida albicans strain SC5314 (ATCC® number: MYA-2876) by PGR using primers 
with restriction digestion sites at the termini. The reaction mixtures of the three ALS 
genes after PCR were loaded in an agarose gel for gel electrophoresis. No PGR 
product was present in the negative control of the PCR reactions of the three ALS 
genes. Single band was observed for the PCR of each ALS genes. The size of the PCR 
products were between 3054bp and 4072bp (Figure 9). 
4.7.2 Ligation of PCR products with pYES6CT plasmids 
Restriction digestion products of the PCR products of ALSl, ALS5 smaller 
allele, and ALS6 were ligated with digested pYES6CT plasmids. Presence of ALS 
genes in the ligated plasmids was confirmed by PCR of the ALS genes from the three 
ligated plasmids. The same primers of the PCR reactions of the three ALS genes were 
used. The reaction mixtures were loaded in an agarose gel for gel electrophoresis. No 
PCR product was present in the negative control of the PCR reactions of the three 
ALS genes. No PCR product was present in the controls of the three ALS genes using 
original pYES6CT plasmid as template. Smear from the top of the gel with a single 
band was observed for the PCR reactions of ALSl, and ALS5 smaller allele using 
ALSl, and ALS5 ligated plasmids as template. Single band was observed for the PCR 
of ALS6 using ALS6 ligated plasmid as template. The band intensity of the PCR 
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product of ALS6 amplified from ligated plasmid was weaker than that of ALSl and 
ALS5 smaller allele. The band size of the PCR products amplified from the three 
ligated plasmids was the same as that from the genomic DNA of Candida albicans 
strain SC5314 (ATCC® number: MYA-2876) (Figure 10). 
4.7.3 DNA sequencing results of ALSl，ALS5 smaller allele, and ALS6 ligated 
plasmids 
The ALS genes inserted into plasmids were sequenced by the DNA 
sequencing services of Macrogen, South Korea. The DNA sequences of the ALS genes 
inserted were compared with the DNA sequences of its corresponding gene retrieved 
from the GenBank of NCBI. The DNA sequences of the ALSl, ALS5 smaller allele, 
and ALS6 genes inserted were shown in appendix II，appendix III，and appendix IV 
resepctively. A base variation in ALSl was observed at the position of 1933^^ bp. The 
original cytosine changed into thymine, leading to a change in amino acid from 
leucine to phenylalaine. Two base variations in ALS5 smaller allele were observed at 
the positions of bp, and of 258th bp. The thymine at the 48 '^' bp changed into 
cytosine, and the guanine at the bp changed into adenine. Both variations were 
synonymous in amino acid level. A base variation in ALS6 was observed at the 
position of 3529^'' bp of the ALS6. The adenine at the 3529 '^' bp changed into guanine, 
leading to a change of amino acid from threonine to alanine. The base variations of 
84 
each gene, with the positions of variations and the amino acid changes were listed in 
Table 2. 
4.7.4 Detection of Alsl, Als5, and Als6 proteins expression 
Expression of Alsl, Als5, and Als6 proteins in transformed Saccharomyces 
cerevisiae was checked by dot blot. Anti-His HRP antibodies bound to the His-tag at 
the tail of each Als protein. Chemiluminescence generated from anti-his HRP leaving 
dark spots on medical imaging film. From the film (Figure 11) dark spot was not 
present in the region corresponding to the PVDF membrane dotted with the cell wall 
lysate of Saccharomyces cerevisiae transformed with empty plasmid. Dark spots were 
detected in the region corresponding to the PVDF membrane dotted with the cell wall 
lysates of Saccharomyces cerevisiae transformed with ALSl, ALS5 smaller allele and 
ALS6. 
4.8 Adhesion of transformed Saccharomyces cerevisiae to fibroblasts 
The confluence of fibroblasts cultured in a T75 culture flask was checked 
after the incubation at 37°C in 5% CO2 and 95% RH for 48 hours. A monolayer of 
fibroblasts of 80% confluence was observed. The fibroblasts were harvested and 
counted. After counting, 2x10^ cells were seeded in each well of two 6-well plates. 
The confluence of fibroblasts cultured in each well of the two culture plates was 
checked. A monolayer of fibroblasts of 100% confluence was observed. The cells 
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were used as substratum for the adhesion assay of Saccharomyces cerevisiae to 
fibroblasts. 
The adherence of the Saccharomyces cerevisiae transformed with ALSl, 
ALS5 smaller allele, or ALS6 was compared with that of Saccharomyces cerevisiae 
transformed with empty pYES6CT plasmid (control). The adherence of the four 
clones of Saccharomyces cerevisiae was represented by percentage of initial inoculum 
adhered to fibroblasts. 
The percentage of initial inoculum of the three clones of ALS transformed 
Saccharomyces cerevisiae was higher than that of control. The percentage of initial 
inoculum adhered to fibroblasts of control, and of Saccharomyces cerevisiae 
transformed with ALSl, ALS5 smaller allele, and ALS6 was 10.36%, 44.87%，24.02%, 
and 27.69% respectively (Table 3 and Figure 12). The statistical significance of the 
difference in the percentage of initial inoculum of the four clones of Saccharomyces 
cerevisiae was tested by non parametric ANOVA, Kruskal-Wallis test. The p value 
was 0.04. The percentage of initial inoculum adhered to fibroblast of all the three 
clones of ALS transformed Saccharomyces cerevisiae was significantly higher than 
that of control. 
4.9 Adhesion of transformed Saccharomyces cerevisiae to FEP, 
polyurethane and silicone catheters 
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The adherence of the Saccharomyces cerevisiae transformed with ALSl, 
ALS5 smaller allele, and ALS6 was compared with that of Saccharomyces cerevisiae 
transformed with empty pYES6CT plasmid (control). The adherence of the four 
clones of Saccharomyces cerevisiae was represented by percentage of initial inoculum 
adhered to the catheter fragments. 
The percentage of initial inoculum adhered to FEP catheter fragments of 
the three clones of ALS transformed Saccharomyces cerevisiae was higher than that of 
control. The percentage of initial inoculum adhered to FEP catheter fragments of 
control, and of Saccharomyces cerevisiae transformed ALSl, ALS5 smaller allele, and 
ALS6 was 0.17%, 3.93%, 0.37%，and 1.01% respectively. The statistical significance 
of the difference in the percentage of initial inoculum of the four clones of 
Saccharomyces cerevisiae was tested by non parametric ANOVA, Kruskal-Wallis test. 
The p value was 0.041. The difference in percentage of initial inoculum between 
control and ALSl, and ALS6 transformed Saccharomyces cerevisiae was statistically 
significant. The percentage of initial inoculum of the Saccharomyces cerevisiae 
transformed with ALS5 smaller allele was not significantly higher than that of control. 
The percentage of initial inoculum adhered to polyurethane catheter 
fragments of the Saccharomyces cerevisiae transformed with ALSl, and with ALS5 
smaller allele was higher than that of control. The percentage of initial inoculum 
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adhered to polyurethane catheter fragments of ALS6 transformed Saccharomyces 
cerevisiae was below the detection limit of the quantitation system. The percentage of 
initial inoculum adhered to polyurethane catheter fragments of control, and 
Saccharomyces cerevisiae transformed with JLS/，and ALS5 smaller allele was 0.16%, 
0.28%, and 0.29% respectively. The statistical significance of the difference in the 
percentage of initial inoculum between the three clones of Saccharomyces cerevisiae 
was tested by non parametric ANOVA, Kruskal-Wallis test. The p value was 0.276 
and the difference was not statistically significant. 
The percentage of initial inoculum adhered to silicone catheter fragments 
of the ALSl transformed Saccharomyces cerevisiae was higher than that of control. 
The percentage of initial inoculum adhered to silicone catheter fragments of the 
Saccharomyces cerevisiae transformed with ALS5 smaller allele was lower than that 
of control. The percentage of initial inoculum of ALS6 transformed Saccharomyces 
cerevisiae was below the detection limit of the quantitation system. The percentage of 
initial inoculum adhered to silicone catheter fragments of control, and of 
Saccharomyces cerevisiae transformed with ALS�’ and ALS5 smaller allele, was 
0.47%, 2.57%, and 0.19% respectively. The statistical significance of the difference in 
the percentage of initial inoculum between the three clones was tested by non 
parametric ANOVA, Kruskal-Wallis test. The p value was 0.768 and the difference 
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was not statistically significant. The percentage of initial inoculum of the four clones 
of Saccharomyces cerevisiae adhered to the FEP, polyurethane, and silicone catheters 
was shown in Table 4 and Figure 13. 
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Chapter 5 Discussion 
5.1 Limitations of static adhesion assay model 
Static adhesion model inherits the limitation of the domination of 
gravitational force as stated in Section 1.7.1. In addition, the shearing effect of fluid 
movement on adhesion of microbial cells cannot be studied by static adhesion model. 
In this study, the use of catheter tubes instead of catheter material discs 
prohibits direct comparison of the adhesive function of Als proteins to different types 
of catheter. The geometry of the FEP, the polyurethane, and the silicone catheters used 
is different as their diameters are different. This affects the probability of 
Saccharomyces cerevisiae cells contacting the catheter surfaces, therefore direct 
comparison of adherence between the three catheters is inappropriate. This problem 
can be solved by using catheter material sheets, which can be tailored into disc of 
same diameter, in turn, the geometry and the surface area. The use of catheter material 
disc offers another advantage of the ease of conducting adhesion assay. Microliter 
plates could be used as adhesion chambers if catheter material discs were used. All the 
cell suspensions applied would be on the top of the disc and cells could sediment on 
and contact the surface of the discs. Adhesion chambers had to be tailor-made, which 
was a tedious work，as catheters were used in this study. However, it is very difficult 
to obtain catheter material sheets due to the unwillingness of catheters manufacturers 
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providing the services, the cost involved, and, the difficulties in transportation of 
these sheets. 
Adherence of different Als proteins is reflected by the percentage of initial 
inoculum remaining on catheter surfaces after the washing process. Ideally, the 
number of Saccharomyces cerevisiae cells adhered on catheter surfaces after washing 
should be the function of the adhesive strength between the cells and catheter surfaces. 
However, as in most adhesion studies, the actual shearing force exerted on cells 
during washing was not defined and controlled. In addition, there is no standard on 
the strength of shearing force for adhesion assay. Without the information of the 
absolute adhesive strength between the cells and catheter surfaces, the result obtained 
from this type of adhesion assay is relative in nature. Therefore, direct comparison 
between different studies is inappropriate unless the washing process is similar. 
5.2 Quantitation System 
5.2.1 Staining method 
The detection limit of the staining method using safranin was 4x10^ cells. 
If 10^ cells were used as the initial inoculum of an adhesion assay, the detection limit 
in terms of percentage of adherence would be 4%. From a number of adhesion assay, 
the percentage of initial inoculum adhered to substrata could be lower than 1% (86). 
Thus this method is not sensitive enough. This method originates from the 
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measurement of biofilm by staining the extracellular matrix of Staphylococcus aureus 
with safranin stain (92). One of the probable reasons explaining the high detection 
limit would be the inability of Candida albicans cell wall in absorbing safranin stain. 
Incomplete destaining by SDS buffer may also account for the high detection limit. 
5.2.2 ATP bioluminescence assay 
The detection limit of the ATP bioluminescence assay was IxlO* cells or 
0.1% in terms of percentage of adherence if IxlO^cells were used as initial inoculum. 
As the detection limit of this assay was 40 times lower than that of the staining 
method and lower than 1 %，ATP bioluminescence assay was used in this study. 
Detection limit of ATP bioluminescence is defined by the following 
equation (108): 
Detection limit = Average Relative Luminescence Unit (RLU) (background)卞 ^^  X 
Standard Deviation (background r l u ) 
The strategy to lower the detection limit is to decrease the background RLU and to 
minimize the variation of background RLU, which will be small if the background 
RLU is low. The background RLU was contributed by the autoluminescence of the 
96-well white assay plates used, the ATP from the medium submerging the catheter 
fragments during measurement, and background contamination. 
Autoluminescence of the white assay plate is due to the emission of energy 
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by the plate after absorbing light. This was prevented by wrapping the white assay 
plates with aluminum foil before use. Yeast peptone dextrose broth and RPMI 1640 
were used in the ATP bioluminescence assay. They carried ATP molecules of the raw 
materials of the medium. It may be prevented by using autoclaved distilled water 
instead of using medium for submerging catheters. A major source of background ATP 
contamination was from the white assay plates as the plates used were not sterile. 
Microbial cells in the wells of the plates increased background signal. Effort was 
made for obtaining sterile white assay plates but was unsuccessful. In addition, the 
adhesion assay of catheters involved a lot of transfer of catheter fragments between 
bijou bottles. These manipulations increased the chance of background contamination 
although sterile forceps were used. It can be improved if catheter material discs were 
used. 
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The bioluminescence reading decreased at cell concentration of 10 cells. 
One possible reason is that cell suspension at this concentration was too turbid and 
blocking the emission of bioluminescence. The upper limit of this system was 10^ 
cells as bioluminescence was not proportional to cell number beyond 10^ cells. 
This quantitation system is useful in studying initial adhesion events 
because the initial inoculum size of this kind of study is usually above 1x10^ cells. 
Therefore, the minimum detection limit of this quantitation system in terms of 
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percentage of initial inoculum would be lower than 1%, which is sufficient to detect 
low level of adherence. In addition, this system is less tedious, and faster than other 
quantitation systems such as sonication and staining, especially if catheter material 
disc is used. The system may also be useful in the study of cell proliferation after 
adhesion. Although the initial inoculum of this kind of study is lower than 1x10^ cells, 
thus the detection limit of this assay, the number of cells after the long incubation time 
may be well above 1x10^ cells. However, biofilm formation is very likely to occur 
after the long incubation time, and the effect of biofilm on the accuracy of the 
quantitation system is unknown. As a result, further experiments have to be conducted 
in order to verify this possible use of the system. Clinical use of this quantitation 
system may not be possible. Quantitation of microorganisms adhered on catheters by 
ATP bioluminescence will kill the microorganisms and the identification of causative 
agents will not be possible. In addition, as a standard curve has to be constructed for 
each species or even each strain of microorganisms in bioluminescence assay, this 
may not be possible to conduct in a clinical microbiology laboratory. 
5.3 Preliminary studies of adherence of Candida albicans to fibroblasts and 
to FEP, polyurethane, and silicone catheters 
The aim of this study is to confirm the adherence of Candida albicans 
strain SC5314 (ATCC® number: MYA-2876) to fibroblasts and to the three catheters 
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tested before cloning of the ALS genes of this strain. Adherence of Candida albicans 
strain SC5314 to fibroblasts was compared with that of Saccharomyces cerevisiae 
(ATCC® number: 96686), which is known to be non adherent. The adherence of the 
Candida albicans to fibroblasts was 22.3 folds higher than that of the Saccharomyces 
cerevisiae. Thus it was believed that Candida albicans strain SC5314 is more 
'adherent' to the fibroblasts. 
In the preliminary study of the adherence of Candida albicans strain 
SC5314 to the three catheters, Candida albicans cells were observed on FEP and on 
polyurethane catheter surfaces. In addition, growth of Candida albicans cells was 
observed in the YPD broth culturing FEP, polyurethane, and silicone catheters, but not 
in the catheters of the control group. It was believed that Candida alibcans cells 
adhered to the three catheters. As this Candida albicans strain is ‘adherent’ to 
fibroblasts and to catheters, the ALS genes from this strain were cloned. 
5.4 Effect of inoculum size on adhesion to catheters 
The aim of this experiment is to determine the inoculum size to be used for 
adhesion assay of catheters. The detection limit of the ATP bioluminescence assay in 
terms of percentage of initial inoculum adhered to catheters can be lowered by 
increasing the initial inoculum size. However, catheter surfaces may be saturated if 
the inoculum size was too high. This may underestimate the adherence of Candida 
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albicans or of transformed Saccharomyces cerevisiae as cells could not contact the 
catheter surfaces (36). Assuming the inherent adherence of Candida albicans cells is 
not affected by the cell density in the surrounding fluid, the percentage of adherence 
of Candida albicans using different initial inoculum size should be the same if the 
catheters were not saturated. 
No statistically significant difference in percentage of initial inoculum 
adhered on catheters was detected using 1x1 O^ ，1x10^  and 1x10^ cells as initial 
inoculum for the three catheters. It suggests that the catheter fragments were not 
saturated. However, an increasing trend in the percentage of adherence was observed 
for all the three catheters as the initial inoculum size decreased. A statistically 
significant result may be obtained if more replicates were conducted. It should also be 
noted that the adhesive strength of the Candida albicans cells may be weak and most 
of the cells were washed away. Statistically significant difference may not be detected 
if too few cells remaining on catheters. 
As there was no statistically significant difference in the percentage of 
initial inoculum adhered on the three catheters at different inoculum size, the 
inoculum size was set at 1x10^ cells in order to minimize the detection limit of the 
ATP bioluminescence assay in terms of percentage of adherence of the ATP 
bioluminescence assay. 
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5.5 Selection of ALS genes 
Saccharomyces cerevisiae was originally transformed with ALSl, ALS3, 
ALS5, and ALS6. Saccharomyces cerevisiae was not transformed with ALS3 because 
ALS3 gene could not be amplified from the genomic DNA of Candida albicans strain 
SC5314 (ATCC® number: MYA-2876) after many effort. ALSl, ALS3, and ALS5 were 
selected because they exhibited adhesion properties to a large array of substrata (86). 
It is likely that they also exhibit adhesion properties to fibroblasts although its 
adherence to FEP, polyurethane, and silicone catheters were not predictable. In 
addition, since the 5’ domains of the three genes which were postulated responsible 
for the adhesion properties share 85% of sequence identity (81，83)，discrepancy in 
the adhesion properties between the three genes to either fibroblasts or catheter 
materials may further support the hypothesis that variations in the hypervariable 
region of the three genes account for the different substrate specificity (86). ALS6 was 
selected for study because its adhesion property was different from that of ALSl’ 
ALS3, and ALS5 (86) and its difference in the sequence identity of the 5' domain (82). 
It was hoped that ALS6 may exhibit adherence to fibroblasts or catheters because this 
may help to explore the substrate specificity of the ALS6 and to identify the 
significance of the 5' domain in the adherence to fibroblasts and to catheters. 
Although the sequence identity of the 5' domain of ALS2，ALS4, ALS7 and ALS9 were 
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different from that of ALSl, ALS3, and ALS5, it is difficult to amplify them from 
genomic DNA of Candida albicans strain SC5314 (ATCC® number: MYA-2876) and 
sequencing of these genes was difficult to perform. As a result, these genes were not 
selected for the study. 
5.6 Adhesion assay of transformed Saccharomyces cerevisiae to fibroblasts 
The aim of this experiment was to study the adherence of Saccharomyces 
cerevisiae transformed with different ALS genes to fibroblasts. The adherence of 
Saccharomyces cerevisiae transformed with ALSl was highest, followed by ALS6, 
ALS5, and Saccharomyces cerevisiae transformed with empty plasmid. The result of 
this experiment also reconfirms the previous finding by Sheppard and associates (86). 
In the experiment conducted by Sheppard and associates (86)， 
Saccharomyces cerevisiae cells transformed with ALSl or ALS5 were adhesive to 
human FaDu oral epithelial cells and to vascular endothelial cells. It is not surprising 
that ALSl and ALS5 transformed Saccharomyces cerevisiae were adhesive to human 
fibroblasts. The result further demonstrated the wide substrate specificity of Alsl 
proteins and Als5 proteins. 
Saccharomyces cerevisiae transformed with ALS6 was shown by Sheppard 
and associates to be not adhesive to the epithelial cells and endothelial cells. Indeed, 
in that experiment, it only adhered to gelatin. Without obvious evidence suggesting 
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the result was an artefact, the high percentage of adherence to fibroblasts of ALS6 
transformed Saccharomyces cerevisiae is surprising. The adhesion of ALS6 
transformed Saccharomyces cerevisiae implicates that the ligands of other Als 
proteins may be very specific. Therefore, it may be worth to test the adherence of 
Als7, Als9 proteins, which were tested to exhibit no or low level of adherence to a 
number of substrata (86)，to a wider range of cells and inanimate materials for the 
discovery of the binding partners of these proteins. The ability for Candida albicans 
to infect many different organs may be partially accounted for if each Als protein has 
a specific binding substrate. In addition, ligands of each Als proteins may be used for 
blocking the adhesion of Candida albicans. 
An interesting observation is that the transformation of empty plasmid may 
increase the adherence of Saccharomyces cerevisiae. The percentage of adherence of 
Sacchromyces cerevisiae in the preliminary study of adherence to fibroblasts was 
0.29% and that of Saccharomyces cerevisiae transformed with empty plasmid in this 
experiment was 10.35%. In addition, the percentage of adherence of all the four 
clones of Saccharomyces cerevisiae was higher than that of Candida albicans 
obtained in the preliminary study. Although the result cannot be compared directly as 
YPD broth was used for the culture of Candida albicans and of Saccharomyces 
cerevisiae in the preliminary study instead of using SC synthetic medium with 
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galactose, it is worth to further investigate whatever the difference was due to the 
medium used or the transformation of plasmid. If the difference was due to the use of 
different medium, it may be worth to investigate if there is any change in gene 
expression profile or in hydrophobicity of Saccharomyces cerevisiae cells. If the 
difference was due to the transformation, it may be worth to investigate if there is any 
change in the gene expression profile of Saccharomyces cerevisiae cells or if there is 
any element of the plasmid causing the difference. 
5.7 Adhesion assay of transformed Saccharomyces cerevisiae to catheters 
The aim of this experiment is to study the adherence to FEP, polyurethane, 
and silicone catheters of Saccharomyces cerevisiae transformed with different ALS 
genes. Transformation of ALSl or ALS6 conferred Saccharomyces cerevisiae cells 
increased adherence to FEP catheters but not to polyurethane, or silicone catheters. 
Transformation of ALS5 did not confer Saccharomyces cerevisiae adherence to all of 
the three catheters. 
Both ALSl and ALS6 transformed Saccharomyces cerevisiae had higher 
adherence to FEP catheters than control but not ALS5 transformed Saccharomyces 
cerevisiae. It is worth to know why transformation of ALS5 gene did not confer 
Saccharomyces cerevisiae adherence to FEP catheters. It should be noted that the 5' 
domain sequence of ALSl and ALS5 shares 85% of identity. It was demonstrated by 
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Sheppard and associates that the N terminal of Als proteins is responsible for the 
adhesive function of the proteins by exchanging the 5' domain sequences of ALS5 and 
of ALS6’ resulting in exchange of adhesion profile (86). The same strategy can be 
used for elucidating which domain is responsible for the adherence to FEP catheters 
by exchanging the 5' domain sequence of ALSl and of ALS5. It may shed light on 
how Als proteins mediate adhesion to catheters. If the adhesive function to FEP 
catheters resides on the N terminal domain, it may be worth to find out if the 
adherence is due to the difference in the hypervariable regions of the N terminal 
domains (86) or factors such as the hydrophobicity of the Als proteins. It should be 
noted that the N terminal domain of Als proteins is hydrophobic. 
Another interesting question is why ALSl and ALS6 transformed 
Saccharomyces cerevisiae did not adhere to silicone catheters. It should be noted that 
the water contact angle of FEP and of silicone are 108° and 109° respectively (42). 
This implicates that the hydrophobicity of the two materials is similar. Although it 
should be noted that direct comparison of adherence to the two catheters is 
inappropriate due to the difference in the geometry and uncertain chemical 
composition of the two catheters, it may still be worthy to further investigate by using 
pure FEP and silicone disc as substrata. It may shed light on the role of 
hydrophobicity in the adhesion of Als proteins to catheters. 
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The hydrophilic nature of polyurethane (water contact angle is 78。）may 
explain why all ALS transformed Saccharomyces cerevisiae clones were not more 
adherent than Saccharomyces cerevisiae transformed with empty plasmid. The 
finding may also explain the clinical observation that the rate of infection associated 
with polyurethane catheters is lower than catheters using other materials (2). However, 
as the Als proteins from only one Candida albicans strain were tested, the result is not 
representative. It may be worth to screen other Candida albicans strains for a range of 
adherence to polyurethane catheters and transformed the ALS genes from those strains 
to Saccharomyces cerevisiae for adhesion assay. 
5.8 Alternative research model 
The studies of the adhesive functions of Als proteins mainly deploy either 
a gain of function study or a loss of function study. Gain of function is conducted by 
transforming a target ALS gene into Saccharomyces cerevisiae, which exhibits no 
adherence, and the adherence of the transformed Saccharomyces cerevisiae is 
measured. Loss of function study is conducted by knocking out the target ALS gene of 
Candida albicans using Ura blasting technique (88)，and the adherence of the mutant 
is measured. 
The gain of function study has the advantage of being easier to produce 
transformed Saccharomyces cerevisiae. However, a positive result (gain in adherence 
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by Saccharomyces cerevisiae) is less confirmative comparing with the loss of 
function study as the possibility of interactions between the protein products of the 
transformed genes and that of the gene from Saccharomyces cerevisiae could not be 
ruled out. The positive result (loss in adherence by Candida albicans mutant) of a loss 
of function study is very confirmative if the result is further confirmed by the 
restoration of adherence by reversing the mutant. However, a negative result in this 
kind of experiment may be the consequence of the compensatory functions exhibited 
by other adhesive proteins of the mutant. In addition, a double mutant of a same gene 
is difficult to obtain (88). 
5.9 Implications and future work 
It is the first time reported that transformation of ALS genes to 
Saccharomyces cerevisiae conferred its adherence to FEP catheters. This study shown 
that cell wall proteins of Candida albicans may contribute to the adhesion of Candida 
albicans cells to catheter surfaces and to fibroblasts. The results also shown that 
different Als proteins exhibited specific adhesion properties to catheters. In terms of 
clinical applications, the identification of cell structures responsible for adhesion of 
Candida albicans cells to catheter surface provided targets for preventing the 
adherence of Candida albicans cells to catheter surface, thus in turn, may reduce the 
incidence of CAI. By disrupting the cell wall proteins or other cell structure 
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responsible for adhesion, or by quenching the function of these structures, the 
adhesion of Candida albicans cells may be prevented. It was previously reported by 
Bjerketorp that adhesive proteins of Staphylococcus aureus were involved in the 
adhesion to CVC coated with serum proteins (109). The two findings together may 
imply that protein molecules of microbial cells may directly participate in adhesion to 
catheters and these proteins may exhibit different specificity or affinity to different 
catheter materials. Therefore, it may be worth to search for other proteins in different 
causative agents of CAI that may also exhibit adhesive function to catheters. By 
studying their adhesion properties to different catheter materials, an adhesion profile 
of different catheter materials can be constructed. The profiling may help to identify 
which catheter materials exhibit lowest affinity to the most common causative 
microorganisms of CAI and in turn, providing microbiological basis in the choice of 
materials for manufacturing catheters with low adherence to microbial cells. 
In the aspect of science in adhesion, the exhibition of specific adhesion 
properties by Alsl protein and Als6 protein to FEP catheters and the exhibition of 
wide substrate specificity to human cells by Alsl protein and Als5 protein raised the 
question of what account for these differences. As the function of a molecule is 
largely determined by its structure, the specificity exhibited by these Als proteins is 
probably related to their structures. The differences in the structure may affect 
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whatever the proteins mediate adhesion through receptor binding, hydrophobicity or 
other mechanisms. And adhesion of Als proteins to cells and to catheters may be 
contributed by different mechanisms. As a result, characterization of the structure of 
these proteins is helpful in solving these questions. Indeed, understanding of the 
structure and function of these proteins is important in developing strategies for 
disrupting the structure or quenching the function of these proteins as the strategies 
for preventing adhesion due to receptor binding is very likely to be different from that 
due to hydrophobicity. This may ultimately decrease the incidence of CAI and 
disseminated candidiasis. Strategies may include altering the hydrophobicity of 
catheter surfaces or coating adhesion blockers on catheter surfaces. 
The role of Als proteins in the pathogenesis of CAI, however, have to be 
further studied and confirmed as there are a lot of questions remain unanswered. 
These questions include whatever these proteins retain their adhesion properties in 
clinical situation, for example, under the shearing force during fluid administration in 
physiological conditions and under the effect drugs administrated; whatever these 
genes are expressed in Candida albicans cells adhered on catheters; whatever these 
proteins adhere to other catheter materials; whatever the Als proteins in other strains 
of Candida albicans also possess the same adhesion properties, and whatever these 
proteins are necessary and sufficient for initiating CAI. All these questions have to be 
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answered before the role of Als proteins in the pathogenesis of CAI can be firmly 
established. 
For future work, first of all, it is necessary to confirm that the increased 
adherence of ALS transformed Saccharomyces cerevisiae to FEP catheters was due to 
the ALS genes instead of other factors associated with transformation. Gain of 
function study was used in this study. The result could be confirmed by loss of 
function study. It can be achieved by knocking out the ALS gene transformed in 
Saccharomyces cerevisiae and measuring its adherence. If the adherence of these 
Saccharomyces cerevisiae was the same as that of Saccharomycese cerevisiae 
transformed with empty plasmid, the increased adherence of ALS transformed 
Saccharomyces cerevisiae was due to the ALS genes. The result can also be confirmed 
by measuring the adherence of Candida albicans with the target ALS gene being 
knocked out. 
Other future work may include studying the adherence of different Als 
proteins under shearing force in physiological conditions using a robbin device, 
studying the adherence of Als proteins of other clinical isolates of Candida albicans, 
investigate the ALS genes expression profile of Candida albicans adhered on catheter 
surfaces etc. 
Sheppard and associates shown that the adhesive functions of Als proteins 
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to endothelial cells and to epithelial cells resides in the N terminal domain and 
proposed that N terminal domain is an immunoglobulin. This finding leads to the 
thinking that Als proteins mediate adhesion through receptor binding. It is worth to 
elucidate if the same N terminal domain is responsible for the adherence of Als 
proteins to FEP catheters. Another strategy for understanding the adhesion 
mechanism of Als proteins is to conduct ELISA to test the adherence of Als proteins 
to a number of different receptors. It may also be worth to investigate if the 
transformation of ALS genes results in a change of cell surface hydrophobicity using 
microbial adhesion to hydrocarbons (MATH) (34). If Als proteins confer adherence 
through receptor binding, it is worth to know what are the ligands for these Als 
proteins. It may be possible that Als proteins which possess a domain with similar 
molecular structure, bind to different ligands, different cells or catheters. This may 
explain the wide range of substrate specificity of Als proteins. 
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Chapter 6 Conclusion 
In this study, it was found that adherence of Candida albicans to 0.5cm of 
FEP, polyurethane, and silicone catheters was not affected by initial inoculum size of 
Candida albicans cells in the range from 1x10^ cells to IxlO? cells. The ATP 
bioluminescence used in this study was more sensitive than the safranin staining 
method. When the initial inoculum size was 1x10^ cells, the ATP bioluminescence 
method can detect 0.1% of adherence, which was sensitive enough for adhesion 
assays aim at studying initial adhesion events. ALSl, ALS5 smaller allele, and ALS6 
contributed to the adherence of Candida albicans to human fibroblasts. ALSl and 
ALS6 contributed to the adherence of Candida albicans only to FEP catheters. ALS5 
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Table 1. Turbidity of YPD broth in the preliminary studies of adherence of Candida 
albicans to FEP, polyurethane, and silicone catheter fragments. Turbid YPD culture 
was marked as ‘+’ and clear YPD culture was marked as ‘-‘. 
Catheters FEP Polyurethane Silicone 
Experimental Group + + + 
Control Group -
120 
Table 2. Nucleotide mutations and consequent amino acid changes in the ALSl, ALS5 
smaller allele, and ALS6 inserted into plasmids. 
Gene Position (bp) Nucleotide change Amino acid change 
ALSl 1933 C - > T Leu -> Phe 
ALS5 smaller 48 T — C Synonymous 
allele 
ALS5 smaller 258 G + A Synonymous 
allele 
ALS6 3529 A + G Thr ^ Ala 
121 
Table 3. The percentage of initial inoculum adhered to fibroblasts of Saccharomyces 
cerevisiae transformed with empty plasmid, ALSl, ALS5 smaller allele, and ALS6. 
ALS5 
smaller 
Clone Control ALS1 allele ALS6 
Percentage of initial inoculum 
adhered to fibroblasts 10.35897 44.86979 24.01747 27.69231 
122 
Table 4. The percentage of initial inoculum of Saccharomyces cerevisiae transformed 
with empty plasmid, ALSl, ALS5 smaller allele, and ALS6 adhered to FEP, 
polyurethane, and silicone catheter fragments. The adherence of ALS6 transformed 
Saccharomyces cerevisiae to polyurethane, and silicone catheters was below the 
detection limit of the assay and was marked as ‘N/A’. 
ALS5 smaller 
Catheter Control ALS1 allele ALS6 
FEP — 0.168706 3.934466 ~ 0.370759 1.017344 
Polyurethan^ 0 . 1 5 8 9 ^ 0 . 2 8 2 2 5 7 0.286522 N/A 
~~Silicone — 0.471769 2.568740 0.192258 N/A 
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Figure 1. Morphology and confluence of fibroblasts, (a) Morphology of fibroblasts 





Figure 3. The percentage of initial inoculum adhered to fibroblasts in the preliminary 
adhesion assay of Candida albicans. 
8 l ———— 
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Figure 4. Surface of FEP catheter fragments and of polyurethane catheter fragments 
after adhesion of Candida albicans. 
^ ^ ^ F E P Polyurethane 
Group fclB Group 
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Figure 5. RT-PCR of ALSl, ALS5 smaller allele, and ALS6 of Candida albicans 
cultured in YPD broth. Lane M: Ikb trackit molecular weight marker; Lane 1: 
negative control of RT-PCR of ALS J; Lane 2: negative control of RT-PCR of ALS5 
smaller allele; Lane 3: negative control of RT-PCR of ALS6; Lane 4: PCR control of 
ALSl using RNA as template; Lane 5: PCR control of ALS5 smaller allele using RNA 
as template; Lane 6: PCR control of ALS6 using RNA as template; Lane 7: RT-PCR of 
ALSl; Lane 8: RT-PCR of ALS5 smaller allele; Lane 9: RT-PCR of ALS6. 





Figure 6. Quantitation system of adhesion assay using absorbance measurement of 
Candida albicans stained with safranin. 
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Figure 7. Quantitation system of adhesion assay using ATP bioluminescence. 
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Figure 8. Effect of inoculum size on adhesion to FEP, polyurethane, and silicone 
catheter fragments. 
Effect of inoculum Size on Adherence 
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Figure 9. PCR of ALSl, ALS5 smaller allele, and ALS6 of Candida albicans. Lane M: 
Ikb trackit molecular weight marker; Lane 1: negative control of ALSl; Lane 2: 
negative control of ALS5 smaller allele; Lane 3: negative control of ALS6; Lane 4: 
PCR of ALSl; Lane 5: PCR of ALS5 smaller allele; Lane 6: PCR of ALS6. 
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Figure 10. Confirmation of ligation of ALS genes by PCR. Lane M: Ikb trackit 
molecular weight marker; Lane 1: negative control of PCR of ALSl; Lane 2: negative 
control of PCR of ALS5 smaller allele; Lane 3: negative control of PCR of ALS6; 
Lane 4: PCR of empty plasmid using ALSl primers; Lane 5: PCR of empty plasmid 
using ALS5 primers; Lane 6: PCR of empty plasmid using ALS6 primers; Lane 7: 
PCR product of ALSl from DNA oi Candida albicans; Lane 8: PCR product of ALS5 
smaller allele from DNA of Candida albicans'. Lane 9: PCR product of ALS6 from 
DNA of Candida albicans; Lane 10: PCR of ALSl from ALSl ligated plasmid; Lane 
11: PCR of ALS5 smaller allele from ALS5 smaller allele ligated plasmid; Lane 12: 
PCR oiALS6 from ALS6 ligated plasmid. 
i 
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Figure 11. Dot blot of cell wall lysates of Saccharomyces cerevisiae transformed with 
empty plasmid, ALSl, ALS5 smaller allele, and ALS6. i p m 
Empty plasmid ALSl smaller a l l e l e ^ ^ ^ ^ ^ ^ ^ ^ g 
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Figure 12. The percentage of initial inoculum of Saccharomyces cerevisiae 
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\ 
Figure 13. The percentage of initial inoculum of Saccharomyces cerevisiae 
transformed with empty plasmid, ALSl, ALS5 smaller allele, and ALS6 adhered to 
FEP, polyurethane and silicone catheters. 
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Appendix I 
Sequence of the sequencing primers of ALSl, AL5 smaller allele, and ALS6. 
Strand 
Gene Sequenced Sequence (5，-3，） TmfC) 
ALSl Sense AATATACCTCTATACTTTAACGTC 50 
ALSl Sense GAATTCACAACTTTTTCTACATTAACATG 51 
ALSl Sense CCGGTTTCATCTGAATCATTTAGTTAC 53 
ALSl Sense TGTTGGTGTGACTACTTCCTATCTGACTA 53 
ALSl Sense TCCAACTGTCACTACAACCGAGTATT 52 
ALSl Sense CACAACTGTAACTGGTCCACCAAGT 53 
ALSl Sense TTTGCCACAACCACCACAGTTACT 54 
ALSl Sense TTTCTTCAACTGATGGTATTAGTGCTACAT 54 
ALSl Sense CCTACAGGTGATAATGGAGACAATACTTC 53 
ALSl Sense GGATCTGTTACTGGTGGAGCTGTT 52 
ALSl Anti- Sense GCGTGAATGTAAGCGTGAC 50 
ALSl Anti- Sense CTTGTAGATGCTGAGGTGCCTGTT 53 
ALSl Anti- Sense GAAGTATTGTCTCCATTATCACCTGTAGG 53 
ALSl Anti- Sense TAGCACTAATACCATCAGTTGAAGAAAGT 52 
ALSl Anti- Sense ACTGTGGTGGTTGTGGCAAATGAT 56 
ALSl Anti- Sense ATAACAGTATCAGTGCCACTTGGTG 51 
ALSl Anti- Sense AATACTCGGTTGTAGTGACAGTTGGAT 53 
ALSl Anti- Sense AGTCAGATAGGAAGTAGTCACACCAACATA 53 
ALSl Anti- Sense ACCGGATAATTCCAATCATTTAATC 51 
ALSl Anti- Sense CATGTTAATGTAGAAAAAGTTGTGAATTC 51 
ALS5 Sense AATATACCTCTATACTTTAACGTC 50 
ALS5 Sense AATGTTTTACTGCTGGTACCAATACGGT 56 
ALS5 Sense TAAGAATAGTGATGCCGGATCTAAC 50 
ALS5 Sense AATTGACACAGTGGTGGTACAAGTTC 52 
ALS5 Sense TATCGTTATACATGATCCATTGGAAG 50 
ALS5 Sense GTTATTACCCATCTAGCACAATTCTG 50 
ALS5 Sense TTGTAACAGGGATACCATCGTCTAGT 51 
ALS5 Sense CAACTCCGTCAAGTCATTCTGAAATA 53 
ALS5 Sense CCAAGTAAAACTAAGTCGATTGAAGA 50 
ALS5 Anti- Sense GCGTGAATGTAAGCGTGAC 50 
137 
ALS5 Anti- Sense GTGGAGTACTGGCAACATTGCTAAA 53 
ALS5 Anti- Sense GTTGAAGAACTAGCACTTGTTTGCAG 53 
ALS5 Anti- Sense GCTTGTTGGGTCACTTGTAAGAGAGA 54 
ALS5 Anti- Sense TGGCATGTCTGAACTTAATGGTATAT 50 
ALS5 Anti- Sense CAGTTCTTCCAATGGATCATGTATAA 50 
ALS5 Anti- Sense CTGGGTTGTAGTTGTAGTTGGATTTG 52 
ALS5 Anti- Sense ATAAATGGACGATAACCGGCAGGAAC 58 
ALS5 Anti- Sense ATGATCTCAAATTATTGTTCACTGTACAT 50 
ALS6 Sense AATATACGACTCCTATAGGA 55 
ALS6 Sense TCAGGCTACCAATTTCATTCAATGTG 55 
ALS6 Sense ATTGTATGGATGGCAAAAAGGGAAAT 56 
ALS6 Sense AACGGATAGTGTGATCATCAAGGAGCCACACAAC 54 
ALS6 Sense CAATTGGGTTAACATCTAGTGAGTCG 5 2 
ALS6 Sense GATTTCTAGTGATTCGGTGTCTCTTAC 50 
ALS6 Sense ATCCAAATATCGACTCACTGCAAACA 55 
ALS6 Sense ACAGTATCATCTGTATCAGTACATTCAATAGA 59 
ALS6 Sense CCAAATTCCTTGATTCATTCAGAGTC 53 
ALS6 Anti- Sense GCGTGAATGTAAGCG 55 
ALS6 Anti- Sense GCTGCCGACGACTTATCATCAA 53 
ALS6 Anti- Sense AAAGTGTTTGGTTCGTTATCTTCGAT 53 
ALS6 Anti- Sense ATCTCCGTTATCACGACGACAAAA 53 
ALS6 Anti- Sense TAGACCTTGCATCACTTGAAACTAAAG 52 
ALS6 Anti- Sense GACAGTTCTTCCAATGGATCATGTATA 52 
ALS6 Anti- Sense ACTTGATGTGGTAGCTGATCCAGTCC 55 
ALS6 Anti- Sense GAAAATGATTCTGATGATACTGGCAT 52 
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